DK142869B - Analogous process for preparing 2,6-dialkyl-4-phenyl-1,4-dihydropyridine-3-carboxylic acid aminoalkyl ester compounds. - Google Patents

Analogous process for preparing 2,6-dialkyl-4-phenyl-1,4-dihydropyridine-3-carboxylic acid aminoalkyl ester compounds. Download PDF

Info

Publication number
DK142869B
DK142869B DK87774AA DK87774A DK142869B DK 142869 B DK142869 B DK 142869B DK 87774A A DK87774A A DK 87774AA DK 87774 A DK87774 A DK 87774A DK 142869 B DK142869 B DK 142869B
Authority
DK
Denmark
Prior art keywords
formula
compound
defined above
ester
acid
Prior art date
Application number
DK87774AA
Other languages
Danish (da)
Other versions
DK142869C (en
Inventor
Toichi Takenaka
Masuo Murakami
Kozo Takahashi
Masaru Iwanami
Masaharu Fujimoto
Tadao Shibanuma
Ryutaro Kawai
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP48020423A external-priority patent/JPS5930704B2/en
Priority claimed from JP2556673A external-priority patent/JPS49109384A/ja
Priority claimed from JP4482173A external-priority patent/JPS5714348B2/ja
Priority claimed from JP5230773A external-priority patent/JPS49135976A/ja
Priority claimed from JP5493973A external-priority patent/JPS504082A/ja
Priority claimed from JP8327673A external-priority patent/JPS5720950B2/ja
Priority claimed from JP13407073A external-priority patent/JPS5084577A/ja
Priority claimed from JP13406973A external-priority patent/JPS5545075B2/ja
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of DK142869B publication Critical patent/DK142869B/en
Application granted granted Critical
Publication of DK142869C publication Critical patent/DK142869C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

(9 \B> (11) fremlæggelsesskrift 142869 DANMARK i«) mt. ci.3 c 07 0 211/90 (21) Ansøgning nr. 877/74 (22) Indleveret den 19· feb. 1974 li&piII (24) Løbedag 19. feb. 1974 V/ (44) Ansøgningen fremlagt og fremlasogebesskriftet offentliggjort den 1 6. feb. 1 981(9 \ B> (11) petition 142869 DENMARK i «) mt. ci.3 c 07 0 211/90 (21) Application No. 877/74 (22) Filed on 19 · Feb. 1974 li & piII (24) Race day 19 Feb. 1974 V / (44) The application presented and the document published on 1 February 6. 1 981

DIREKTORATET FORDIRECTORATE OF

PATENT- OG VAREMÆRKEVÆSENET (30) '‘"oÉet begæret fra denTHE PATENT AND TRADEMARKET SYSTEM (30) '' "

20. feb. 1975, 20425/754 JPFeb 20 1975, 20425/754 JP

5. mar. 1975, 25566/734 JP 20. apr. 1975, 44821/73, JPMar 5 1975, 25566/734 JP Apr 20 1975, 44821/73, JP

11. maj 1975, 52507/754 JPMay 11, 1975, 52507/754 JP

17. maj 19754 54959/754 JPMay 17, 19754 54959/754 JP

24. jul. 1975, 83276/734 JPJuly 24. 1975, 83276/734 JP

29. nov. 1975, 154069/754 JPNov 29 1975, 154069/754 JP

29. nov. 1973, 154070/754 JPNov 29 1973, 154070/754 JP

(71) YAMANOUCHI PHARMACEUTICAL CO. LTD., 5-14 Nihoribashi-Honcho 2-chome, "Chuo-ku, Tokyo, JP.(71) YAMANOUCHI PHARMACEUTICAL CO. LTD., 5-14 Nihoribashi-Honcho 2-chome, "Chuo-ku, Tokyo, JP.

(72) Opfinder: Masuo Murakami, 19-1-502, Sengoku 2-chome, Bunkyo-ku, Tokyo, JP: Kbzo TakahasKi, 8574 Nishioizumi-cho, Nerima-ku, Tokyo, JP:(72) Inventor: Masuo Murakami, 19-1-502, Sengoku 2-chome, Bunkyo-ku, Tokyo, JP: Kbzo TakahasKi, 8574 Nishioizumi-cho, Nerima-ku, Tokyo, JP:

Mas aru Iwanami, 8-1, Nishikigaoka, Kohoku-ku, Yokohama-shi, Kanagawa, JP: Magaharu Fujimoto, 840, Hokima, Adachi-ku, Tokyo, JP: Tadao Shlba= numa, 14-32, Saiwai-cho 2-chome, Asakl-øhi, saitama, JP: Ryufcaro Kawai, 1547-5, Koguki, Shiraoka-machi, Mlnamisalt ama-gun, saitama, TP: Toichl Takenaka, 17—18—807, Akabanedai 4-chome, Kita-ku, Tokyo, JP.Mas aru Iwanami, 8-1, Nishikigaoka, Kohoku-ku, Yokohama-shi, Kanagawa, JP: Magaharu Fujimoto, 840, Hokima, Adachi-ku, Tokyo, JP: Tadao Shlba = numa, 14-32, Saiwai-cho 2 -chome, Asakl-øhi, saitama, JP: Ryufcaro Kawai, 1547-5, Koguki, Shiraoka-machi, Mlnamisalt ama-gun, saitama, TP: Toichl Takenaka, 17—18—807, Akabanedai 4-chome, Kita-ku , Tokyo, JP.

(74) Fuldmægtig under sagens behandling:(74) Plenipotentiary in the proceedings:

Ingeniørfirmaet Hofman-Bang & Boutard.Hofman-Bang & Boutard Engineering Company.

(64) Analogifremgangsmåde til fremstilling af 2, 6-dialkyl-4-phenyl-1,4-dihydropyrldin-5-carboxylsyre-amlnoalkylester-forbindelser.(64) Analogous process for the preparation of 2,6-dialkyl-4-phenyl-1,4-dihydropyridine-5-carboxylic acid aminoalkyl ester compounds.

Opfindelsen angår en analogifremgangsmåde til fremstilling af hidtil ukendte 2,6-dialkyl-4-phenyl-l,4-dihydropyridin-3-carboxyl-syre-aminoalkylester-forbindelser med den i kravets indledning angivne almene formel (I), hvilke forbindelser har en udmærket cerebral vasculodilatorisk aktivitet.This invention relates to an analogous process for the preparation of novel 2,6-dialkyl-4-phenyl-1,4-dihydropyridine-3-carboxylic acid aminoalkyl ester compounds having the general formula (I) as set forth in the preamble of claim 1, excellent cerebral vasculodilatory activity.

Af l,4-dihydropyridin-3,5-dicarboxylsyre-derivater har 4-(nitrosubstitueret phenyl)-2,6-dimethyl-l,4-dihydropyridin-3,5-dicarboxylsy-re-diethylester længe været kendt og er beskrevet i f.eks. Chem.Of 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives, 4- (nitrosubstituted phenyl) -2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester has long been known and is described in eg. Chem.

Ber., 20, 1338-1343 (1889) og J. Am. Chem. Soc., 71, 4003-4007 (1949). Andre kendte eksempler er l,4-dihydropyridin-3,5-dicarbo-xylsyre-alkoxyalkylestere, som er beskrevet i US patentskrifterne nr. 3 485 847 og 3 511 847 og de tyske offentliggørelsesskrifter nr. 1 813 436, 2 013 431 og 2 018 738.Ber., 20, 1338-1343 (1889) and J. Am. Chem. Soc., 71, 4003-4007 (1949). Other known examples are 1,4-dihydropyridine-3,5-dicarboxylic acid alkoxyalkyl esters, which are described in U.S. Patents Nos. 3,485,847 and 3,511,847 and German Publication Nos. 1,813,436, 2,013,431 and 2 018 738.

2 1428692 142869

Blandt disse kendte forbindelser er 4-(2’-nitrophenyl)-2,6-dimethyl- 1.4- 'dihydropyridin-3,5-dicarboxylsyre-methylester velkendt som en forbindelse, der udviser coronar vasodilatorisk aktivitet og spas-molytisk aktivitet (US patentskrift nr. 3 485, 847) (godkendt under navnet "Nifedipine" af the British Pharmacopoea Commission). Det er også kendt, at l,4-dihydro-2,6-dimethyl-4-(2-trifluormethylphe-nyl)-3,5-pyridin-dicarboxylsyre-diethylester har blodtryksænkende aktivitet (se f.eks.US patentskriftnr. 3 511 847). Imidlertid har det aldrig været kendt i praksis, at disse kendte forbindelser har cerebral vasculodilatorisk aktivitet.Among these known compounds, 4- (2'-nitrophenyl) -2,6-dimethyl-1,4- 'dihydropyridine-3,5-dicarboxylic acid methyl ester is well known as a compound exhibiting coronary vasodilatory activity and spasmolytic activity (US Patent Nos. 3 485, 847) (approved under the name "Nifedipine" by the British Pharmacopoea Commission). It is also known that 1,4-dihydro-2,6-dimethyl-4- (2-trifluoromethylphenyl) -3,5-pyridine-dicarboxylic acid diethyl ester has blood pressure lowering activity (see, e.g., U.S. Patent No. 3 511 847). However, it has never been known in practice that these known compounds have cerebral vasculodilatory activity.

Fra dansk patentansøgning nr. 2089/73 kendes 4-phenyl-2,6-dimethyl- 1.4- dihydropyridin-5-alkoxycarbonyl (eller alkanoyl)-3-carboxyl-syre-aminoalkylestere med cerebral vasculodilatorisk aktivitet.Danish Patent Application No. 2089/73 discloses 4-phenyl-2,6-dimethyl-1,4-dihydropyridine-5-alkoxycarbonyl (or alkanoyl) -3-carboxylic acid aminoalkyl esters with cerebral vasculodilatory activity.

Det har nu ifølge opfindelsen vist sig, at de hidtil ukendte forbindelser med formlen (I) har musculotropisk spasmolytisk aktivitet såvel som en særlig fremtrædende cerebral vasculodilatorisk aktivitet i forbindelse med lav toxicitet, og at de frembringer en meget stærkere og længerevarende vasculær dilatation end de ovennævnte kendte forbindelser. Derfor er disse forbindelser særlig egnet til at ophæve tillukningen af den cerebrale vasculære blodstrøm.It has now been found according to the invention that the novel compounds of formula (I) have muscularotropic spasmolytic activity as well as a particularly prominent low toxicity cerebral vasculodilatory activity and that they produce a much stronger and longer lasting vascular dilatation than the above known compounds. Therefore, these compounds are particularly suitable for abrogating the closure of the cerebral vascular blood stream.

Disse med nitrogenholdige grupper substituerede alkylestere af 1,4-dihydropyridin-3,5-dicarboxylsyre er som nævnt hidtil ukendte, og det var uventet at sådanne nye forbindelser ville vise sig at have de ovenfor beskrevne aktiviteter.These nitrogen-substituted alkyl esters of 1,4-dihydropyridine-3,5-dicarboxylic acid are novel as mentioned and it was unexpected that such new compounds would appear to have the above-described activities.

Fremgangsmåden ifølge opfindelsen er ejendommelig ved det i kravets kendetegnende del anførte.The process according to the invention is characterized by the characterizing part of the claim.

Ved den i kravet angivne procedure (a) omsættes forbindelserne med formlerne (II), (III) og (IV) i væsentligt ækvimolære forhold i ikke-opløst tilstand eller i et opløsningsmiddel, såsom ethanol, isopropanol, dioxan, dimethylformamid, dimethylsulfoxid og aceto-nitril. Reaktionen kan fremmes ved opvarmning af reaktionssystemet.In the procedure (a) of the claim, the compounds of formulas (II), (III) and (IV) are reacted in substantially equimolar conditions in an insoluble state or in a solvent such as ethanol, isopropanol, dioxane, dimethylformamide, dimethylsulfoxide and aceto -nitril. The reaction can be promoted by heating the reaction system.

Som angivet i kravet fremstilles enamin-derivatet med formlen (IV) ved omsætning af en β-diketon-forbindelse med formlen (V) og en atm‘n 3 142869 med formlen (XVI) og isolering af produktet før brugen, men den følgende metode kan selvfølgelig anvendes: forbindelsen med formlen (V) bringes til at reagere med en i det væsentlige ækvimolær mængde eller en overskydende molær mængde af aminen med formlen (XVI) i en reaktionsbeholder, fortrinsvis i nærvær af et organisk opløsningsmiddel, såsom ethanol, til dannelse af forbindelsen med den almene formel (IV), hvorefter forbindelsen med formlen (II) og forbindelsen med formlen (III) sættes til reaktionsblandingen uden isolering af forbindelsen (IV).As set forth in the claim, the enamine derivative of formula (IV) is prepared by reacting a β-diketone compound of formula (V) and an atm of formula (XVI) and isolating the product before use, but the following method Of course, the compound of formula (V) may be reacted with a substantially equimolar amount or an excess molar amount of the amine of formula (XVI) in a reaction vessel, preferably in the presence of an organic solvent such as ethanol. of the compound of general formula (IV), after which the compound of formula (II) and compound of formula (III) are added to the reaction mixture without isolation of compound (IV).

Ved den i kravet angivne procedure (b) omsættes benzaldehyd-deri-vatet med formlen (II) med enamin-forbindelsen med formlen (VI) og forbindelsen med formlen (V) under de samme betingelser som ved procedure (a). På lignende måde som under procedure (a) fremstilles enamin-forbindelsen med formlen (VI) ved omsætning af forbindelsen med den almene formel (III) og aminen med den almene formel (XVI), og forbindelsen med formlen (il) og forbindelsen med formlen (V) kan sættes til reaktionsblandingen uden isolering af forbindelsen med formlen (VI).In the procedure (b) of the claim, the benzaldehyde derivative of formula (II) is reacted with the enamine compound of formula (VI) and the compound of formula (V) under the same conditions as in procedure (a). Similar to procedure (a), the enamine compound of formula (VI) is prepared by reacting the compound of the general formula (III) and the amine of the general formula (XVI), and the compound of the formula (II) and the compound of the formula (V) can be added to the reaction mixture without isolating the compound of formula (VI).

Når forbindelsen med formlen (VI) eller forbindelsen med formlen (IV) fremstilles ved omsætning af forbindelsen med formlen (III) eller forbindelsen med formlen (V) med forbindelsen med formlen (XVI) under de ovenstående procedurer, foretrækkes det at anvende forbindelsen med formlen (VI) i væsentligt ækvimolær mængde eller overskydende mængde i forhold til forbindelsen med formlen (III) eller forbindelsen med formlen (V), og om nødvendigt at tilsætte forbindelsen med formlen (XVI) som en opløsning i et organisk opløsningsmiddel, såsom methanol og ethanol. Hvis der anvendes en overskydende mængde af forbindelsen med formlen (VI), er det desuden nødvendigt efter reaktionen at fjerne overskydende forbindelse med formlen (XVI) fra reaktionsblandingen ved koncentrering under formindsket tryk før produktet omsættes med andre reaktanter, dvs. forbindelsen med formlen (II) og forbindelsen med formlen (III) eller forbindelsen med formlen (II) og forbindelsen med formlen (V) .When the compound of formula (VI) or compound of formula (IV) is prepared by reacting the compound of formula (III) or compound of formula (V) with the compound of formula (XVI) under the above procedures, it is preferred to use the compound of formula (VI) substantially equimolar or excess amount relative to the compound of formula (III) or the compound of formula (V), and if necessary to add the compound of formula (XVI) as a solution in an organic solvent such as methanol and ethanol . In addition, if an excess amount of the compound of formula (VI) is used, it is necessary after the reaction to remove excess compound of formula (XVI) from the reaction mixture by concentration under reduced pressure before reacting the product with other reactants, i.e. the compound of formula (II) and the compound of formula (III) or the compound of formula (II) and the compound of formula (V).

142869 4142869 4

Ved den i kravet angivne procedure (c) "bringes lavere-alkanoylkanel-syre-alkylesteren med formlen (Vil) R6 R3 f\—CH=C-COOA-N^ (VII) I 2 \ 4 COR^ R* 2 3 a ^ hvori R , R , R , R og A har den i kravets indledning angivne betydning, til at reagere med forbindelsen med formlen (IV), og ved procedure (d) bringes forbindelsen med den almene formel (VIII) R6 CH=C-COR5 (VIII) COR1 15 6 hvori R , R og R har den i kravets indledning angivne betydning, til at reagere med forbindelsen med formlen (VI).In the procedure (c) of the claim, the lower alkanoyl cinnamic acid alkyl ester of formula (Vil) R6 R3 is obtained by -CH = C-COOA-N ^ (VII) I 2 \ 4 COR ^ R * 2 3 a wherein R, R, R, R and A are as defined in the preamble of claim 1 to react with the compound of formula (IV), and by procedure (d), the compound of general formula (VIII) R COR5 (VIII) COR1 15 wherein R, R and R are as defined in the preamble of the claim to react with the compound of formula (VI).

Ved den i kravet angivne procedure (e) bringes forbindelsen med den ovenstående formel (VII) til at reagere med forbindelsen med formlen (V) og aminen med formlen (XVI), og ved procedure (f) bringes forbindelsen med den ovenstående formel (VIII) til at reagere med forbindelsen med formlen (III) og aminen med formlen (XVI).In the procedure (e) according to the claim, the compound of the above formula (VII) is reacted with the compound of the formula (V) and the amine of the formula (XVI) and by the procedure (f) the compound of the above formula (VIII) ) to react with the compound of formula (III) and the amine of formula (XVI).

Ved den i kravet angivne procedure (g) omsættes forbindelsen med formlen (II), forbindelsen med formlen (III), forbindelsen med formlen (V) og forbindelsen med formlen (XVI) i ækvimolære forhold, fortrinsvis i et organisk opløsningsmiddel.In the procedure (g) of the claim, the compound of formula (II), the compound of formula (III), the compound of formula (V) and the compound of formula (XVI) are reacted in equimolar ratios, preferably in an organic solvent.

5 1428695 142869

Endelig ved den i kravet angivne procedure φι) omsættes fortin-del sen med formlen (II), forbindelsen med formlen (IV) og en forbindelse med den almene formel R2-C0CH2-C00A-X (IX) p hvori X betyder et halogenatom, og R og A har den i kravets indledning angivne betydning, til dannelse af en forbindelse med formlen D"r6 r5oc \ cooa-x (X) kFinally, by the procedure set out in the claim φι), the compound of formula (II), the compound of formula (IV) and a compound of the general formula R2-COCH2-C00A-X (IX) p wherein X represents a halogen atom are reacted. and R and A are as defined in the preamble of the claim to form a compound of formula D "r6 r5oc \ cooa-x (X) k

Ί O CΊ O C

hvori R, R , R , R , R og A har den i kravets indledning angivne betydning, og X har den ovennævnte betydning, hvorpå denne forbindelse bringes til at reagere med en amin med formlen /R3 ΗΝΓ (XI)wherein R, R, R, R, R and A have the meaning set forth in the preamble of claim and X has the above meaning upon which this compound is reacted with an amine of formula / R3 ΗΝΓ (XI)

VV

X 4 hvori R^ og R har den i kravets indledning angivne betydning.X 4 wherein R 1 and R are as defined in the preamble of claim.

De ved de forskellige ovenstående procedurer fremstillede produkter kan isoleres og renses ved almindelige kemiske operationer, såsom ekstraktion, sø,jlekromatografi, omkrystallisation og lignende.The products prepared by the various above procedures can be isolated and purified by ordinary chemical operations such as extraction, lake, gel chromatography, recrystallization and the like.

Forbindelserne med den almene formel (I) kan med fordel omdannes til terapeutisk uskadelige salte, f.eks. salte med mineralsyrer, såsom hydrochlorider, sulfater og phosphater, eller salte med organiske 6 142869 syrer, såsom acetater, fumarater, maleater og tartrater.The compounds of general formula (I) may advantageously be converted into therapeutically harmless salts, e.g. salts with mineral acids such as hydrochlorides, sulfates and phosphates, or salts with organic acids such as acetates, fumarates, maleates and tartrates.

Den passende dosis af de ved fremgangsmåden ifølge opfindelsen fremstillede forbindelser til indgivelse på en gang hos mennesker er 0,1 - 0,5 mg ved intravenøs indgivning og 5 - 10 mg-ved oral ind-givning, og dosering to eller tre gange om dagen er passende.The appropriate dose of the compounds of the present invention for once-in-human administration is 0.1 - 0.5 mg by intravenous administration and 5 - 10 mg by oral administration, and dosing two or three times a day. is appropriate.

Som eksempler på lavere alkylgrupper, som repræsenteres af R, R^, o c R , R og R5 i forbindelserne med den almene formel (I), kan nævnes methyl, ethyl, propyl, isopropyl, n-butyl og tert-butyl, og som eksempler på lavere alkoxygrupper, som repræsenteres af , kan nævnes methoxy, ethoxy, propoxy, isopropoxy, n-butoxy, iso-butoxy, tert-butoxy og pentyloxy. Som eksempler på lavere alkoxygrupper substitueret med en lavere alkoxygruppe, som repræsenteres af R, kan nævnes methoxymethoxy, 2-methoxyethoxy, 2-ethoxyethoxy, 2-propoxyethoxy, 2-methoxypropoxy, 2-propoxypropoxy, 5-methoxypen-tyloxy og 3-methoxypentyloxy. Som eksempler på alkylengrupper, som repræsenteres af A i den almene formel (i), kan nævnes methylen, ethylen, trimethylen, tetramethylen, propylen og ethylethylen.Examples of lower alkyl groups represented by R, R 4, and R 5, R 5 and R 5 in the compounds of general formula (I) may be mentioned methyl, ethyl, propyl, isopropyl, n-butyl and tert-butyl, and as Examples of lower alkoxy groups represented by include methoxy, ethoxy, propoxy, isopropoxy, n-butoxy, iso-butoxy, tert-butoxy and pentyloxy. Examples of lower alkoxy groups substituted by a lower alkoxy group represented by R include methoxymethoxy, 2-methoxyethoxy, 2-ethoxyethoxy, 2-propoxyethoxy, 2-methoxypropoxy, 2-propoxypropoxy, 5-methoxypene-tyloxy and 3-methoxypentyloxy. Examples of alkylene groups represented by A in the general formula (i) include methylene, ethylene, trimethylene, tetramethylene, propylene and ethylethylene.

Resultaterne af prøvninger af de ved fremgangsmåden ifølge opfindelsen fremstillede forbindelsers cerebrale vasodilaterende aktivitet er anført i den følgende tabel.The results of tests of the cerebral vasodilating activity of the compounds of the invention are set forth in the following table.

Metode: Voksne bastardhunde blev anæstetiseret med natriumpento- barbital (30 mg/kg,- i.v.) og fik kunstigt åndedræt. Den vertebrale blodstrøm blev målt med en elektromagnetisk strømningsmåler anbragt rundt om karret. LD^Q blev målt ved anvendelse af mus. Resultaterne er anført i den følgende tabel.Method: Adult bastard dogs were anesthetized with sodium pentobarbital (30 mg / kg, - i.v.) and given artificial respiration. The vertebral blood flow was measured with an electromagnetic flow meter placed around the vessel. LD ^Q was measured using mice. The results are given in the following table.

ØpN02 R^OC—COO-A-N"^ . HC1 11 JI p^· CH-TY^CH, 3 “ 3 7 142869Open NO2 R 2 OC-COO-A-N 4 HCl 11 JI p 2 · CH-TY 2 CH 3 3 3 7 142869

Prøve ' Vertebral blod- LDj-n 5 3 4 strøms effektiv R A R R dosis (mg/kg,i.v.) (mg/kg, ______i.v.Sample Vertebral Blood LDj-n 5 3 4 Current Effective R A R R Dose (mg / kg, i.v.) (Mg / kg, ______ i.v.

CH^O- -CH2CH2- O “CH2" ch3“ 0,0003 - 0,01 20,7 c2h5o- " " " " " 15 CH^ncho- " " CH^ » -CH2CH2CH2- ” C2H5- " " 12 n -CH2CH2- CH30-Q-CH2- CH^ „ „ 10 C2H50- " C1-Q-CH2- " 10 n « n 0,001 - 0,01 i2 CH3- ” 0“CH2" " 0,001 “ °»001 40 " " C1-0-CH2- " " " 45CH2 O- -CH2CH2- O “CH2" ch3 "0.0003 - 0.01 20.7 c2h5o-" "" "" CH ^ ncho- "" CH2 "-CH2CH2CH2-" C2H5- "" 12 n -CH2CH2- CH30-Q-CH2- CH2 "" 10 C2H50- "C1-Q-CH2-" 10 n «n 0.001 - 0.01 i2 CH3-" 0 "CH2" "0.001" ° "001 40" " C1-0-CH2- "" "45

Nifedipin 0,001 - 0,01 5,6 I det følgende anføres resultater af sammenligningsforsøg med et antal forbindelser fremstillet ifølge dansk patentansøgning nr. 2089/73 og et antal forbindelser fremstillet ifølge den foreliggende opfindelse med papaverin som standard. Vasodilatationen og toxiciteten blev målt på samme måde som beskrevet ovenfor, og vasodilatationens styrke derpå sat i forhold til den, der frembringes af papaverin.Nifedipine 0.001 - 0.01 5.6 The following are the results of comparative experiments with a number of compounds prepared according to Danish Patent Application No. 2089/73 and a number of compounds made according to the present invention with papaverine as standard. The vasodilatation and toxicity were measured in the same manner as described above, and the strength of the vasodilatation was then compared to that produced by papaverine.

8 1428698 142869

Almen formel for forbindelserne fremstillet ifølge opfindelsen og ifølge dansk patentansøgning nr. 2089/73.The general formula for the compounds of the invention and of Danish Patent Application No. 2089/73.

XX

%0C\^k/00RA% 0C \ ^ K / 00RA

Jf jiCCf jiC

CH^'N CJH, J H 3CH ^ A CJH, J H 3

Vasodilatation LD,-nVasodilatation LD, -n

Ra 1¾ X Styrke Varighed mg/£g i<v_Ra 1¾ X Strength Duration mg / £ g in <v_

Papaverin 1 - f 27,0Papaverin 1 - f 27.0

Forbindelser fremstillet ifølge ans. nr. 2089/73:Compounds prepared according to Ans. No. 2089/73:

Prøve nr.Sample no.

a -CH2CH2N-H -°ch3 ^rN°2 1 ++ 46,7a -CH2CH2N-H - ° ch3 ^ rN ° 2 1 ++ 46.7

Xch3 VXch3 V

b -CH-CH-N—CH, " " 10 " 53,0 2 2 n. i CH3 c -CH2CH2N—CH3 " " " ” 33,0 'C2H5 d -CH2CH2N—C2H5 " " 39,5 \2h5 e -CH2CH2nQ ” " " 33,0 f -CH2CH2CH2N— CH3 " " " 29 i5b -CH-CH-N-CH, "" 10 "53.0 2 2 n. in CH3 c -CH2CH2N-CH3" "" 33.0 'C2H5 d -CH2CH2N-C2H5 "" 39.5 \ 2h5 e -CH2CH2nQ "" "33.0 f -CH2CH2CH2N— CH3" "" 29 i5

Sch3 g -CH-CH-N—CH- " " " " 301° I 2 \ 3 CH- CH- J . CH- I 3 h -CH2CH2N—CH3 -OCH2CH2N " ‘ 1 t 70,0 XCH3 Cii3 i » -0CH3 " 10 53,0 j " ”OC2H5 " " " 37 j° k " . ·-OCH—CH- " n t++ 37,0 \ Δ CH3 9 142869Sch3 g -CH-CH-N-CH- "" "" 301 ° I 2 \ 3 CH- CH- J. CH-I 3 h -CH2CH2N-CH3 -OCH2CH2N "1 t 70.0 XCH3 C133" -0CH3 "10 53.0 j" "OC2H5" "37 j ° k" · -OCH-CH- "n t ++ 37.0 \ Δ CH3 9 142869

Vasodilatation LD^qVasodilatation LD ^ q

Prøve nr. RA_Re X Styrke Varighed . l v_ 1 -CH^CH^N—CH, -OCH-CH, fl^fN02 10 T++ 4210 2 2 S \h5 ^ m , " -0C(CH3)3 " " +f 50,0 n " -OCH2CH-€H3 " * " " ,CH, o -°C^CH2 " C2H5 P " -OeH2CH2OCH2CH2CH3 " " " 29,5 q “OC2H5 1 f 25,3 r " " 48,1 |^CH3 s " - (fV001^ " ** 28,0 T q£|| t " -och3 3 " f 53,4 U " " (JV01 10 H 18,0Sample No. RA_Re X Strength Duration. l v_ 1 -CH 2 CH 2 N-CH, -OCH-CH, fl 2 fNO 2 10 T ++ 4210 2 2 S \ h 5 ^ m, "-0C (CH 3) 3" "+ f 50.0 n" -OCH 2 CH- € H3 "*" ", CH, o - ° C ^ CH2" C2H5 P "-OeH2CH2OCH2CH2CH3" "" 29.5 q “OC2H5 1 f 25.3 r" "48.1 | ^ CH3 s" - (fV001 ^ "** 28.0 T q £ || t" -and 3 "f 53.4 U" "(JV01 10 H 18.0

Xci v " - p 1 f 43,1 w - " l$LNo2 10 H 20,5 x " " ¢^°2 " " 53,0 F°2 y " " Q 0,3 + 76,6 z -(pCH2N—CH3 " ΐφΐΝ0 10 ++ 1013 CH3 xch3 2 Z ’ -CHjCHjH—CH3 -CH3 β~Ν02 " + 85,0 CH_ J uoplø-Xci v "- p 1 f 43.1 w -" l $ LNo2 10 H 20.5 x "" ¢ ^ ° 2 "" 53.0 F ° 2 y "" Q 0.3 + 76.6 z - ( pCH2N-CH3 "ΐφΐΝ0 10 ++ 1013 CH3 xch3 2 Z '-CH2CH2H-CH3 -CH3 β ~ Ν02" + 85.0 CH_ J

z·· -CH2CH2^d^j -OCH3 i^m2 - +Hz ·· -CH2CH2 ^ d ^ j -OCH3 i ^ m2 - + H

z"' -CH2CH2N— CH3 “0CH3 δ °r3 " 25 J° \h3 10 142869z "-CH2CH2N— CH3" 0CH3 δ ° r3 "25 J ° \ h3 10 142869

Forbindelser fremstillet Tr ..Compounds made from Tr ..

ifølge opfindelsen: vasodilatation id^qaccording to the invention: vasodilatation id ^ q

Prøve nr. RA RB X Styrke Varighed mg/kg i.v.Sample No. RA RB X Strength Duration mg / kg i.v.

a -CH2CH2N-H _0CH3 (Γ^ΓΝ°2 30 +Ή- 16,0a -CH2CH2N-H _0CH3 (Γ ^ ΓΝ ° 2 30 + Ή- 16.0

'<12-© Y'<12- © Y

b -CH,CH,N—CH-, " " 200 +H4 20,7 c -CH2CH2N—C2H5 -OCH-CH3 " n 13,5b -CH, CH, N-CH-, 200 + H4 20.7 c -CH2CH2N-C2H5 -OCH-CH3 n 13.5

V,-© XV, - © X

d -CH9CH_N—CH- " ” " 7,4d -CH9CH_N-CH- "" "7.4

Xch2-^-ch3 e -CH2CH2N—CH3 “OVE " " " 8»6 xch2-^-och3 f -CH2CH2N—CH3 “0CH3 " " " 6,0 -Q-ci g -CH0CH0CH„N-CH, -OCH-CH- " " " 9,7 2 2 2 \ 2 \ 3 CB2-© ch3 h -CH2CH2N—CH3 -OCH3 " " " 16,5 CH2-® i -CH2CH2N—CH3 -Coils 30 t+t 23,7Xch2 - ^ - ch3 e -CH2CH2N-CH3 "OVE" "8" 6 xch2 - ^ - and3 f -CH2CH2N-CH3 "OCH3" "6.0 -Q-ci g -CHOCHOCH" N-CH, -OCH -CH- "" "9.7 2 2 2 \ 2 \ 3 CB2- © ch3 h -CH2CH2N-CH3 -OCH3" "" 16.5 CH2 -® in -CH2CH2N-CH3-Coils 30 t + t 23.7

Xch2-^ ^ 3 j " " (prCF3 " " 14,0 k n " . A 200 ++++ " ^Γ1°2 1 -CH0CHoN-CH, . -OCHCH ' (¾ " " 0,6 2 2 'o1-© åe3 3 ^1>2 m " -CH3 jt^fN02 100 +++ 40,7 n -CH~CH_N—CH, " " " " 50,0 2 2 \ 3 /=rvXch2- ^ 3 j "" (prCF3 "" 14.0 kn ". A 200 ++++" ^ Γ1 ° 2 1 -CHOCHoN-CH, -OCHCH '(¾ "" 0.6 2 2' o1 - © åe3 3 ^ 1> 2 m "-CH3 jt ^ fN02 100 +++ 40.7 n -CH ~ CH_N-CH," "" "50.0 2 2 \ 3 / = rv

Cl : Papaverin = 1 s1 : f : 5-10 min. ++ : 10-20 min. +++ : 20-30 min. ++++ : 30-50 min.Cl: Papaverine = 1 s1: f: 5-10 min. ++: 10-20 min. +++: 20-30 min. ++++: 30-50 min.

11 14286911 142869

De følgende farmakologiske data repræsenterer den cerebrale vaso-dilaterende aktivitet, den spasmolytiske aktivitet og den akute toxicitet af forbindelsen 2,6-dimethyl-4-(3’-nitrophenyl)-1,4-di-hydropyridin-3,5-dicarboxylsyre 3-β-(N-benzyl-N-me thy1amino) ethyl-ester-5-methylester hydrochlorid ( i det følgende kaldet forbindelse "A”) i sammenligning med aktiviteterne af papaverin og nifedipin.The following pharmacological data represent the cerebral vasodilatory activity, the spasmolytic activity and the acute toxicity of the compound 2,6-dimethyl-4- (3'-nitrophenyl) -1,4-dihydropyridine-3,5-dicarboxylic acid 3 -β- (N-benzyl-N-me thylamino) ethyl ester-5-methyl ester hydrochloride (hereinafter called compound "A") in comparison with the activities of papaverine and nifedipine.

1. Virkning på den cerebrale cirkulation, hjertehastigheden og blodtrykket efter intravenøs injektion:1. Effect on cerebral circulation, heart rate and blood pressure after intravenous injection:

Metode: Voksne bastardhunde blev anæstetiseret med natriumpento- barbital (30 mg/kg, i.v.) og fik kunstigt åndedræt. Den vertebrale blodstrøm blev målt med en elektromagnetisk strømningsmåler anbragt rundt om karret. Blodtrykket ved femoralarterien blev målt ved hjælp af en tryk-transducer og hjertehastigheden ved hjælp af et cardio-tachometer. Alle midler blev indgivet i femoralvenen.Method: Adult bastard dogs were anesthetized with sodium pentobarbital (30 mg / kg, i.v.) and given artificial respiration. The vertebral blood flow was measured with an electromagnetic flow meter placed around the vessel. The blood pressure of the femoral artery was measured by a pressure transducer and the heart rate by a cardio-tachometer. All agents were administered into the femoral vein.

Resultater: Virkningerne af forbindelse A, papaverin og nifedipin på den vertebrale blodstrøm, middelblodtrykket og hjertehastigheden hos anæstetiserede hunde er anført i den følgende tabel.Results: The effects of compound A, papaverine and nifedipine on the vertebral blood flow, mean blood pressure and heart rate of anesthetized dogs are listed in the following table.

TabelTable

Middel Dosis Antal dyr Vertebral Middel- Hjerte- (mg/kg) i.v. blodstrøm blodtryk hastighed tø# ± s.a.) (Δ mmHg (A slag/min + s.a.) + s.a.)Mean Dose Number of animals Vertebral Mean Heart (mg / kg) i.v. blood flow blood pressure speed th # ± s.a.) (Δ mmHg (A stroke / min + s.a.) + s.a.)

Papaverin 0,1 8 22 ί 3,4 -9-1,1 8 i 1,5 0,3 8 67 - 7,1 -21 ί 2,8 22 - 3,5 1,0 8 124 ί 13,8 -32 ± 3,5 44 i 4,8Papaverin 0.1 8 22 ί 3.4 -9-1.1 8 i 1.5 0.3 8 67 - 7.1 -21 ½ 2.8 22 - 3.5 1.0 8 124 ί 13.8 -32 ± 3.5 44 in 4.8

Nifedipin 0,001 5 47 ί 13,5 -10 - 1,6 10 ± 3,5 0,003 4 104 t 25,8 -24 ± 5,9 18 i 3,2 0,01 6 135 ~ 28,8 -39 - 5,2 17 - 4,0Nifedipine 0.001 5 47 δ 13.5 -10 - 1.6 10 ± 3.5 0.003 4 104 t 25.8 -24 ± 5.9 18 3.2 3.2 6 135 ~ 28.8 -39 - 5 , 2 17 - 4.0

Forbindelse A 0,0003 8 27 - 4,4 -1 i 0,6 4 i 1,3 0,001 8 61 t 9,5 -7 ί 1,5 12 ί 2,2 0,003 8 132 ί 13,8 -14 i 2,2 18 ± 2,0 0,01 8 200 ί 27,3 -29 - 3,6 25 - 5,3 2. Direkte virkning på cerebrale og femorale arterier: 12 142869Compound A 0.0003 8 27 - 4.4 -1 in 0.6 4 in 1.3 0.001 8 61 t 9.5 -7 δ 1.5 12 ί 2.2 0.003 8 132 ί 13.8 -14 i 2.2 18 ± 2.0 0.01 8 200 ί 27.3 -29 - 3.6 25 - 5.3 2. Direct effect on cerebral and femoral arteries: 12 142869

Til analyse af midlernes selektive virkning på vasculaturen undersøgtes den direkte virkning på den cerebrale (vertebral arterie) og periferale (femoral arterie) vasculære bane ved den konstante volumen-perfusionsmetode.To analyze the selective effect of the agents on the vasculature, the direct effect on the cerebral (vertebral artery) and peripheral (femoral artery) vascular pathway was investigated by the constant volume perfusion method.

Metode: Voksne bastardhunde blev anæstetiseret med natriumpento- barbital (30 mg/kg, i.v.) og fik kunstigt åndedræt. Heparin (1000 enh/ kg, i.v.) anvendtes som antikoagulant . Metoderne til perfusion af hver arterie var som følger: l) For vertebralarterien blev arterie- blodet, der ledtes fra den venstre almene carotidarterie, opsamlet af et tygon-rør og perfuseret ved hjælp af en Sigma-motorpumpe til den højre vertebral arterie. 2) For den femorale arterie blev arterieblodet, der ledtes fra den proximale femoral arterie, perfuseret ved hjælp af Sigma-motorpumpen ind i den distale femorale arterie. De' vasculære reaktioner blev udtrykt som ændringer i perfusionstrykket, der blev målt ved hjælp af en tryktransducer. Alle midler blev givet ind i et gummi rør forbundet tæt til hver arteriekanyle ved hjælp af en microinjector. Dosisreaktionskurven for hvert middel blev bestemt, og den 50% effektive dosis (ED^Q) for hvert middel blev udregnet, når den maximale reaktion på papaverin ved 3000yUg i.a. blev udtrykt som 100% reaktion.Method: Adult bastard dogs were anesthetized with sodium pentobarbital (30 mg / kg, i.v.) and given artificial respiration. Heparin (1000 units / kg, i.v.) was used as an anticoagulant. The methods for perfusion of each artery were as follows: l) For the vertebral artery, the arterial blood that was directed from the left general carotid artery was collected by a tygon tube and perfused by a Sigma motor pump to the right vertebral artery. 2) For the femoral artery, the arterial blood flowing from the proximal femoral artery was perfused by means of the Sigma motor pump into the distal femoral artery. The 'vascular responses were expressed as changes in the perfusion pressure measured by a pressure transducer. All means were given into a rubber tube connected tightly to each artery cannula by means of a microinjector. The dose response curve for each agent was determined and the 50% effective dose (ED ED Q) for each agent was calculated when the maximum response to papaverine at 3000 µg i.a. was expressed as 100% reaction.

Resultater: Virkninger af intra-arterielt indgivet papaverin, nifedipin og forbindelse A på vertebral og femoral arterie er anført i den følgende tabel.Results: Effects of intra-arterially administered papaverine, nifedipine and compound A on vertebral and femoral artery are listed in the following table.

TabelTable

Vasodilatation s.a. Selektivitetsforhold ED,-n /Ug - (EDcn i femoral arterie ' /ED?q i vertebral arterieVasodilatation s.a. Selectivity ratio ED, -n / Ug - (EDcn in femoral artery / ED? Q in vertebral artery

Middel Antal dyr Vertebral Femoral ^ arte rie arterieMean Number of animals Vertebral Femoral ^ arte rie artery

Papaverin 4 72,8 - 8,71 48,8 t 3,73 0,67Papaverine 4 72.8 - 8.71 48.8 t 3.73 0.67

Nifedipin 4 0,74± 0,15 0,37^ 0,11 0,50Nifedipine 4 0.74 ± 0.15 0.37 ^ 0.11 0.50

Forbindelse A 4 0,66- 0,20 0,86-0,11 1,30 3. Spasmolytisk aktivitet: 13 142869Compound A 4 0.66- 0.20 0.86-0.11 1.30 3. Spasmolytic Activity: 13 142869

Metoder: Isoleret marsvin-ileum blev suspenderet i Tyrodes-opløsning ved hjælp af et Magnus-apparat, og musklens bevægelser blev optegnet på en kymograph af en isotonisk vægtstang. Bariumchlorid, acetyl-cholin og histamin anvendtes som agonist, og 50% irihibering ved hjælp af antagonisten blev målt ud fra kontraktionssvaret på agonisten.Methods: Isolated guinea pig ileum was suspended in Tyrodes solution using a Magnus apparatus, and muscle movements were recorded on a kymograph of an isotonic lever. Barium chloride, acetylcholine and histamine were used as agonist, and 50% inhibition by the antagonist was measured from the contraction response of the agonist.

Resultater:results:

TabelTable

Spasmolytisk aktivitet (g/ml-s.a.)Spasmolytic activity (g / ml-s.a.)

Agonist Koncentra- Papaverin Nifedipin Forbindelse AAgonist Concentrate- Papaverine Nifedipine Compound A

_ tion (g/ml) _—_(g / ml) -

BaCl2 2 x 10~4 (7,2±0,2) x ΙΟ'6 (3,3±0,2) x 10”9 (1,9*0,4)x 10~9 cholto" 10'7 (l,1*0,1) x 10-5 (l,6*1,1) x 10~8 (5,2*l,0)x ΗΓ9BaCl2 2 x 10 ~ 4 (7.2 ± 0.2) x ΙΟ'6 (3.3 ± 0.2) x 10 "9 (1.9 * 0.4) x 10 ~ 9 cholesterol" 10'7 (l, 1 * 0.1) x 10-5 (l, 6 * 1.1) x 10 ~ 8 (5.2 * l, 0) x ΗΓ9

Histamin 10"7 (7,0*1,9) x 10"6 (5,5*0,9) x ΙΟ”8 (l,8±0,2)x 10"9 4. Akut toxicitet:Histamine 10 "7 (7.0 * 1.9) x 10" 6 (5.5 * 0.9) x ΙΟ "8 (1.8 ± 0.2) x 10" 9 4. Acute toxicity:

Sammenligning af den intravenøse akutte toxicitet mellem forbindelse A og nifedipin blev udført ved anvendelse af ICR-hanmus og bastardhunde .Comparison of the intravenous acute toxicity between compound A and nifedipine was performed using ICR male and bastard dogs.

Tabel LD (mg/kg, i.v.)Table LD (mg / kg, i.v.)

Prøve Mus -3 HundeSample Mice -3 Dogs

Forbindelse A 20,7 6,1Compound A 20.7 6.1

Nifedipin 5,6 1,5Nifedipine 5.6 1.5

Ud fra de ovenstående resultater har de ved fremgangsmåden ifølge opfindelsen fremstillede forbindelser kraftig spasmolytisk aktivitet, kraftig og selektiv cerebral vasodilaterende aktivitet og lav toxicitet. Derfor er de nyttige til behandling af akut anfald af acclusiv cerebral vasculær sygdom og apoplexi og postapoplectisk tilstand stammende fra cerebrale vasculære uregelmæssigheder ved både injection og langtids-oral indgivning.From the above results, the compounds prepared by the process of the invention have strong spasmolytic activity, vigorous and selective cerebral vasodilating activity and low toxicity. Therefore, they are useful in the treatment of acute attacks of occlusive cerebral vascular disease and apoplexy and postapoplectic conditions arising from cerebral vascular irregularities in both injection and long-term oral administration.

Fremgangsmåden ifølge opfindelsen belyses nærmere ved de efterfølgende eksempler.The process according to the invention is further illustrated by the following examples.

14 142869 EKSEMPEL 1EXAMPLE 1

En blanding af 5 g acetoeddikesyre-p-(N-benzyl-N-methylamino) ethylester, 2,8 g β-aminocrotonsyre-isopropylester og 3 g m-nitro-benzaldehyd blev omrørt i 6 timer ved 100°C på et oliebad» Derefter blev der ved behandling af produktet som i det nedenstående eksempel 2 opnået 2,5 g 2,6-dimethyl-4-(3*-nitrophenyl)-1,4-dihydropyridin-3,5-dicarboxylsyre-5 -isopropylester-3-.β- (N-benzyl-N-methylamino)-ethylester-hydrochlorid.A mixture of 5 g of acetoacetic acid β- (N-benzyl-N-methylamino) ethyl ester, 2.8 g of β-aminocrotonic acid isopropyl ester and 3 g of m-nitrobenzaldehyde was stirred for 6 hours at 100 ° C on an oil bath. Then, by treating the product as in Example 2 below, 2.5 g of 2,6-dimethyl-4- (3 * -nitrophenyl) -1,4-dihydropyridine-3,5-dicarboxylic acid-5-isopropyl ester-3 was obtained. -.β- (N-benzyl-N-methylamino) ethyl ester hydrochloride.

Smeltepunkt: 171 - 175°CMelting point: 171 - 175 ° C

Element analyse for CggH^N^OgCl:Elemental Analysis for CggH ^N ^OgCl:

Ctø) Htø) Ntø) Cl(°/o) beregnet: 61,82 6,30 7,72 6,52 fundet: 61,58 6,15 7,42 6,50 EKSEMPEL 2Ct (Ht) (Nt) Cl (° / o) Calcd: 61.82 6.30 7.72 6.52 Found: 61.58 6.15 7.42 6.50 Example 2

En blanding af 4,98 g acetoeddikesyre-N-benzyl-N-methylaminoethyl-ester, 2,3 g β-aminocrotonsyre-methylester og 3 g m-nitrobenzalde-hyd blev omrørt i 6 timer ved 100°C på et oliebad. Reaktionsblandingen blev underkastet en silicagel-søjlechromatografi (diameter 4 cm og højde 25 cm) og derpå elueret med en 20:1 blanding af chloroform og acetone. Eluatet indeholdende det ønskede produkt blev koncentreret og -undersøgt ved tyndtlagschromatografi.A mixture of 4.98 g of acetoacetic acid N-benzyl-N-methylaminoethyl ester, 2.3 g of β-aminocrotonic acid methyl ester and 3 g of m-nitrobenzaldehyde was stirred for 6 hours at 100 ° C on an oil bath. The reaction mixture was subjected to a silica gel column chromatography (diameter 4 cm and height 25 cm) and then eluted with a 20: 1 mixture of chloroform and acetone. The eluate containing the desired product was concentrated and assayed by thin layer chromatography.

Det således opnåede pulverformede produkt blev opløst i acetone, og efter indstilling af opløsningen til pH 1-2 med en ethanolop-løsning mættet med hydrogenchlorid blev opløsningen koncentreret, hvorved der blev opnået 2 g 2,6-dimethyl-4-(3’-nitrophenyl)-1,4-dihydropyridin-3,5-dicarboxylsyre-5 -methylester-3- β- (N-benzyl-methylamino)-ethylester-hydrochlorid. Det således opnåede produkt blev derpå krystalliseret fra en acetone/ether-blanding;The powdered product thus obtained was dissolved in acetone and, after adjusting the solution to pH 1-2 with an ethanol solution saturated with hydrogen chloride, the solution was concentrated to give 2 g of 2,6-dimethyl-4- (3'- nitrophenyl) -1,4-dihydropyridine-3,5-dicarboxylic acid 5-methyl ester-3- β- (N-benzylmethylamino) ethyl ester hydrochloride. The product thus obtained was then crystallized from an acetone / ether mixture;

Smeltepunkt: 136-140°C (dekompe)Melting point: 136-140 ° C (decomp.)

Elementanalyse for C^qH^qN^C^CI: C tø) Htø) Ntø) Cl tø) beregnet: 60,52 5,86 8,14 6,87 fundet: 60,25 5,87 7,88 6,67 15 142869 I 6 ml methanol opløstes 2,0 g af de ovenfor opnåede krystaller og opløsningen blev koncentreret tander formindsket tryk. Til den således opnåede karamel-ligende remanens sattes 10 ml acetone, og opløsningen blev omrørt under isafkøling. Herved blev der opnået 1,5 g af det ovennævnte produkt med et smeltepunkt på 168-170°C.Elemental analysis for C ^ qHHNNNC ^Cl: C t)) Htø)) Ntø) Cl tøø calculated: 60.52 5.86 8.14 6.87 Found: 60.25 5.87 7.88 6.67 In 6 ml of methanol, 2.0 g of the crystals obtained above were dissolved and the solution concentrated concentrated to reduced pressure. To the caramel-like residue thus obtained was added 10 ml of acetone and the solution was stirred under ice-cooling. There was obtained 1.5 g of the above product with a melting point of 168-170 ° C.

EKSEMPEL 5EXAMPLE 5

En blanding af 4,2 g acetoeddikesyre^-(N-methyl-N-phenylamino) ethylester, 2,05 g β-aminocrotonsyre-methylester og 2,68 g m-nitrobenzaldehyd blev omrørt i 5 timer ved 100°C på oliebad. Reaktionsblandingen blev underkastet en silicagel-søjlechromatogra-fi (diameter 4 cm, højde 25 cm) og derpå elueret med en chloroform/ acetone-blanding i volumenforholdet 20:1. Eluatet blev undersøgt ved tyndtlagschromatografi, og eluatet indeholdende det ønskede produkt blev opsamlet og koncentreret under formindsket tryk hvorved produktet krystalliseredes. Krystallerne blev opsamlet og omkrystalliseret fra en blanding af ether og petroleums-ether, hvorved der blev opnået 0,9 g 2,6-dimethyl-4-(3'-nitro-phenyl)-l,4-dihydropyridin-3,5-dicarboxylsyre-5-methylester-3 -β-(N-methyl-N-phenyl)aminoethylester.A mixture of 4.2 g of acetoacetic acid β - (N-methyl-N-phenylamino) ethyl ester, 2.05 g of β-aminocrotonic acid methyl ester and 2.68 g of m-nitrobenzaldehyde was stirred for 5 hours at 100 ° C on an oil bath. The reaction mixture was subjected to a silica gel column chromatography (diameter 4 cm, height 25 cm) and then eluted with a chloroform / acetone mixture in a 20: 1 volume ratio. The eluate was assayed by thin layer chromatography and the eluate containing the desired product was collected and concentrated under reduced pressure to crystallize the product. The crystals were collected and recrystallized from a mixture of ether and petroleum ether to give 0.9 g of 2,6-dimethyl-4- (3'-nitro-phenyl) -1,4-dihydropyridine-3,5- dicarboxylic acid 5-methyl ester 3-β- (N-methyl-N-phenyl) aminoethyl ester.

Smeltepunkt: 135-138°C.Melting point: 135-138 ° C.

Elementanalyse for C25H27^3^6: C(%) H(%) ' N(%) beregnet: 64,50 5,85 9,03 fundet: 64,48 5,81 8,95 EKSEMPEL 4 I 3 ml isopropanol opløstes 4,4 g acetoeddikesyre^-(N-benzyl-N-methylamino)ethylester, 2,6 g β-aminocrotonsyre-isopropylester og 2,7 g o-nitrobenzaldehyd, og den således fremstillede opløsning blev opvarmet i 5 timer til 80°C. Reaktionsblandingen blev opløst i 50 ml chloroform, hvorpå opløsningen blev vasket med 20 ml 10% saltsyre og 20 ml vand og yderligere med 30 ml 10% vandig natriumhydroxidopløsning og 20 ml vand. Det således dannede chloroformlag blev skilt fra, tørret over vandfrit magnesiumsulfat, og chloroformet afdestilleret under formindsket tryk. Den dannede 16 142869 remanens blev opløst i en lille mængde chloroform, og den fremstillede opløsning blev underkastet en silicagel—søjlechromatogra-fi (diameter 3 cm, højde 20 cm). Produktet blev elueret med en chloroform/acetone-blanding i volumenforholdet 20:1. Elnatet blev undersøgt ved tyndtlagschromatografi, og elnatet indeholdende det ønskede produkt blev opsamlet og koncentreret under formindsket tryk, hvorved der blev opnået 2,2 g 2,6-dimethyl-4-(2f-nitrophenyl)-1,4-dihydropyridin-3,5-dicarboxylsyre-5-isopro-pyle ster-3-β-(N-b enzyl-N-methylamino)ethyle ster. Produktet blev opløst i acetone, og efter neutralisering af opløsningen med ethanol mættet med hydrogenchlorid blev opløsningen koncentreret under formindsket tryk, hvorved der blev opnået hydrochloridet af den ovennævnte forbindelse.Elemental Analysis for C25H276.36: C (%) H (%) N (%) Calculated: 64.50 5.85 9.03 Found: 64.48 5.81 8.95 Example 4 In 3 ml of isopropanol was dissolved 4.4 g of acetoacetic acid 2 - (N-benzyl-N-methylamino) ethyl ester, 2.6 g of β-aminocrotonic acid isopropyl ester and 2.7 g of o-nitrobenzaldehyde, and the solution thus prepared was heated for 5 hours to 80 ° C. . The reaction mixture was dissolved in 50 ml of chloroform, then the solution was washed with 20 ml of 10% hydrochloric acid and 20 ml of water and further with 30 ml of 10% aqueous sodium hydroxide solution and 20 ml of water. The chloroform layer thus formed was separated, dried over anhydrous magnesium sulfate, and the chloroform distilled off under reduced pressure. The residue formed was dissolved in a small amount of chloroform and the solution prepared was subjected to a silica gel column chromatography (diameter 3 cm, height 20 cm). The product was eluted with a chloroform / acetone mixture in a 20: 1 volume ratio. The eluate was examined by thin layer chromatography and the eluate containing the desired product was collected and concentrated under reduced pressure to give 2.2 g of 2,6-dimethyl-4- (2f-nitrophenyl) -1,4-dihydropyridine-3, 5-dicarboxylic acid 5-isopropyl ester 3-β- (Nb enzyl-N-methylamino) ethyl star. The product was dissolved in acetone and, after neutralizing the solution with ethanol saturated with hydrogen chloride, the solution was concentrated under reduced pressure to give the hydrochloride of the above compound.

Smeltepunkt: 208-210°C (dekomp.).Melting point: 208-210 ° C (decomp.).

Elementanalyse for C«) H tø) N«) Cl«) beregnet: 61,82 6,30 7,72 6,52 fundet: 61,63 6,25 7,65 6,73 EKSEMPEL 5 I 5 ml isopropanol opløstes 5,0 g acetoeddikesyre-(N-benzyl-N-methylamino )propylester, 2,7 g β-aminocrotonsyre-isopropylester og 2,9 g m-nitrobenzaldehyd, og opløsningen blev opvarmet til 80°C i 5 timer.Elemental Analysis for C «)H t )N «Cl Cl: 61.82 6.30 7.72 6.52 Found: 61.63 6.25 7.65 6.73 EXAMPLE 5 In 5 ml of isopropanol was dissolved 5 , 0 g of acetoacetic acid (N-benzyl-N-methylamino) propyl ester, 2.7 g of β-aminocrotonic acid isopropyl ester and 2.9 g of m-nitrobenzaldehyde and the solution was heated to 80 ° C for 5 hours.

Derefter blev der ved behandling af reaktionsblandingen som i eksempel 4 opnået 3,1 g 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridin-3,5-dicarboxylsyre-5-isopropylester-3-9^-(N-benzyl-N-methylamino)propylester. Smeltepunktet for hydrochloridet af denne forbindelse var l66-l69°C (dekomp.).Then, by treating the reaction mixture as in Example 4, 3.1 g of 2,6-dimethyl-4- (3'-nitrophenyl) -1,4-dihydropyridine-3,5-dicarboxylic acid 5-isopropyl ester 3-9 was obtained. ^ - (N-benzyl-N-methylamino) propyl ester. The melting point of the hydrochloride of this compound was 1666-169 ° C (decomp.).

Elementanalyse for C^H^gN^OgCl: C (96) H(96) N(96) Cl(%) beregnet: 62,41 6,50 7,53 6,35 fundet: 62,35 6,39 7,41 6,55 17 142869 EKSEMPEL 6 I 3 ml isopropanol opløstes 4,0 g acetoeddikesyre-P-(N-benzyl-N-methylamino)ethylester, 2,1 g β-aminocrotonsyre-ethylester og 2,4 g m-nitrobenzaldehyd, hvorpå opløsningen blev opvarmet til 80°C i 5 timer.Elemental analysis for C ^H ^ gNNO OgCl: C (96) H (96) N (96) Cl (%) calcd: 62.41 6.50 7.53 6.35 found: 62.35 6.39 7, EXAMPLE 6 In 3 ml of isopropanol was dissolved 4.0 g of acetoacetic acid P- (N-benzyl-N-methylamino) ethyl ester, 2.1 g of β-aminocrotonic acid ethyl ester and 2.4 g of m-nitrobenzaldehyde. whereupon the solution was heated to 80 ° C for 5 hours.

Derefter blev der ved behandling af det således opnåede produkt som i eksempel 4 opnået 1,5 g 2,6-dimethyl-4-(3,-nitrophenyl)- 1,4-dihydropyridin-3,5-dicarboxylsyre-5 -ethylester-3-β-(N-benzyl-N-methylamino)ethylester. Resultaterne af elementanalysen på hydrochloridet af dette produkt er som følger:Then, by treating the product thus obtained as in Example 4, 1.5 g of 2,6-dimethyl-4- (3, -nitrophenyl) -1,4-dihydropyridine-3,5-dicarboxylic acid 5-ethyl ester was obtained. 3-β- (N-benzyl-N-methylamino) ethyl ester. The results of the elemental analysis on the hydrochloride of this product are as follows:

Smeltepunkt: 168 - l69°C.Melting point: 168-169 ° C.

Element analyse for : C(%) H(9é) N(%) Cl(%) beregnet 61,19 6,09 7,93 6,69 fundet: 6l,43 6,33 7,66 6,59 EKSEMPEL 7 I 6 ml isopropylalkohol opløstes 2,6 g β-aminocrotonsyre-β-(N-benzyl-N-methylamino)ethylester, 1,1 g methylacetoacetat og 1,5 g m-nitrobenzaldehyd, og den fremstillede opløsning blev omrørt i 6 timer ved 85°C.Elemental Analysis for: C (%) H (9e) N (%) Cl (%) Calc'd 61.19 6.09 7.93 6.69 Found: 6.13, 6.33 7.66 6.59 Example 7 I 6 ml of isopropyl alcohol were dissolved 2.6 g of β-aminocrotonic acid β- (N-benzyl-N-methylamino) ethyl ester, 1.1 g of methyl acetoacetate and 1.5 g of m-nitrobenzaldehyde and the solution prepared was stirred for 6 hours at 85 ° C.

Reaktionsblandingen blev afkølet, opløst i 10 ml chloroform, og opløsningen vasket en gang med overskud af fortyndet saltsyre og derpå tre gange med hver gang 7 ml vand. Det dannede chloro-formlag blev skilt fra, tørret over vandfrit magnesiumsulfat, og chloroformet derpå afdestilleret. Ved blanding af remanensen med 15 ml ethylacetat efterfulgt af omrøring krystalliserede produktet, som blev skilt fra, tørret og omkrystalliseret fra acetone, hvorved der blev opnået 2,4 g krystaller af 2,6-dimethyl- 4-(3'-ni trophenyl)-1,4-dihydropyri din-3,5-di c arboxylsyre-5-methyl-ester-3^-(N-benzyl-N-methylamino)ethylester-hydrochlorid.The reaction mixture was cooled, dissolved in 10 ml of chloroform, and the solution washed once with excess dilute hydrochloric acid and then three times with 7 ml of water each time. The resulting chloroform layer was separated, dried over anhydrous magnesium sulfate, and the chloroform then distilled off. By mixing the residue with 15 ml of ethyl acetate followed by stirring, the separated product crystallized, dried and recrystallized from acetone to give 2.4 g of 2,6-dimethyl-4- (3'-ni trophenyl) crystals. -1,4-dihydropyridine-3,5-di-carboxylic acid 5-methyl-ester-3β- (N-benzyl-N-methylamino) ethyl ester hydrochloride.

Smeltepunkt: 128-132°C (dekomp.).Melting point: 128-132 ° C (decomp.).

Elementanalyse for C^gH^øNjjOgCl 1/2CH-jC0CH^ : C (96) H(9é) N(96) Cl (96) beregnet: 60,60 6,10 7,71 6,50 fundet: 60,6l 6,14 7,46 6,71 EKSEMPEL 8 18 142869 I 20 ml isopropylalkohol opløstes 5,0 g p-aminocrotonsyre-p-dimethylaminoethylester, 7,2 g acetoeddikesyre-β-(N-benzyl-N-methylamino)ethylester og 4,3 g m-nitrobenzaldehyd, og den dannede opløsning blev omrørt i 5 timer ved 85°C· Efter afslutning af reaktionen blev reaktionsblandingen afkølet, opløst i 50 ml ethylåcetat, og produktet derpå ekstraheret en gang med overskud af saltsyre og derpå tre gange med hver gang 50 ml vand. Alle ekstrakterne blev kombineret, og efter alkalisering af opløsningen med en fortyndet vandig opløsning af natriumhydroxid blev produktet ekstraheret med chloroform. Chloroformekstrakten blev tørret over vandfrit magnesiumsulfat, koncentreret, renset ved silicagel-søjlechromatografi under anvendelse af ethylacetat som elueringsmiddel, og de ønskede fraktioner derpå opsamlet. Blandingen blev koncentreret, gjort sur med ethanolisk hydrogen-chlorid, og opløsningsmidlet afdestilleret, hvorved der blev opnået 4,0 g af krystallinsk pulver af 2,6-dimethyl-4-(3’-nitro-phenyl) -1,4-dihydropyridin-3,5-dicarboxylsyre-3-P- (N-benzyl-N-methylamino)ethylester-5-β- (N ,N-dime thyl amino)ethylester.Elemental analysis for C ^ gH ^ øN₂OgClCl / 2CH-CCOCH ^: C (96) H (9e) N (96) Cl (96) calculated: 60.60 6.10 7.71 6.50 found: 60.6l 6 Example 14 18 142869 In 20 ml of isopropyl alcohol was dissolved 5.0 g of p-aminocrotonic acid p-dimethylaminoethyl ester, 7.2 g of acetoacetic acid β- (N-benzyl-N-methylamino) ethyl ester and 4, 3 g of m-nitrobenzaldehyde and the resulting solution was stirred for 5 hours at 85 ° C. After completion of the reaction, the reaction mixture was cooled, dissolved in 50 ml of ethyl acetate, and the product was extracted once with excess hydrochloric acid and then three times with each. once 50 ml of water. All the extracts were combined and, after alkalizing the solution with a dilute aqueous solution of sodium hydroxide, the product was extracted with chloroform. The chloroform extract was dried over anhydrous magnesium sulfate, concentrated, purified by silica gel column chromatography using ethyl acetate as eluant, and the desired fractions were then collected. The mixture was concentrated, acidified with ethanolic hydrogen chloride and the solvent distilled off to obtain 4.0 g of crystalline powder of 2,6-dimethyl-4- (3'-nitro-phenyl) -1,4-dihydropyridine. -3,5-dicarboxylic acid 3-β- (N-benzyl-N-methylamino) ethyl ester 5-β- (N, N-dimethylamino) ethyl ester.

. Elementanalyse for C29H38N4°6C12: C(%) E(%) N(%) Cl(%) beregnet: 57,14 6,28 9,18 11,63 fundet: 57,02 6,56 8,93 11,83. Elemental analysis for C 29 H 38 N 4 ° 6 Cl 2: C (%) E (%) N (%) Cl (%) calculated: 57.14 6.28 9.18 11.63 found: 57.02 6.56 8.93 11.83

Magnetisk kerneresonansspektrum (CDCl^): S (ppm): 2,27 (9H, -N<~|-3 (6H) + {3H) ) 2,31 (3H), 2,41 (3H) ( ]tjf , 2,6 - 2,8 (4H, -CH-,-N< ) 3,64 (2H, -N<ch_0 ) 4,2 - 4,4 (4H, -COQ-CEL- ) 5,28 (IH, )Nuclear Magnetic Resonance Spectrum (CDCl3): S (ppm): 2.27 (9H, -N <~ | -3 (6H) + (3H)) 2.31 (3H), 2.41 (3H) ( 2.6 - 2.8 (4H, -CH -, - N <) 3.64 (2H, -N <ch_O) 4.2 - 4.4 (4H, -COQ-CEL-) 5.28 (1H ,)

HH

7,4 - 8,4 (9H, ' (5H) + (φΤ^2 (4H) } 19 142869 EKSEMPEL 9 I 12 ml isopropylalkohol opløstes 4,0 g acetoeddikesyre-p-(N-benzyl-N-methylamino)ethylester, 1,22 g m-nitrobenzaldehyd og 1,3 ml ammoniakvand, og den dannede opløsning blev omrørt i 6 timer ved 85°C. Derefter blev der ved behandling af den således opnåede reaktionsblanding som i eksempel 8 opnået 3,0 g krystallinsk pulver af 2,6-dimethyl-4-(2'-nitrophenyl)-l,4-dihydropyri-din-3,5-dicarboxylsyre-bi s/β-(N-benzyl-N-methylamino)ethyl7ester-bydrochlorid.7.4 - 8.4 (9H, '(5H) + (φΤΤ 2 (4H)) EXAMPLE 9 In 12 ml of isopropyl alcohol, 4.0 g of acetoacetic acid p- (N-benzyl-N-methylamino) ethyl ester was dissolved , 1.22 g of m-nitrobenzaldehyde and 1.3 ml of ammonia water, and the resulting solution was stirred for 6 hours at 85 ° C. Then, by treating the reaction mixture thus obtained as in Example 8, 3.0 g of crystalline powder was obtained. of 2,6-dimethyl-4- (2'-nitrophenyl) -1,4-dihydropyridine-3,5-dicarboxylic acid bi-β- (N-benzyl-N-methylamino) ethyl ester hydrochloride.

Elementanalyse for C^H^N^OgClg i C(%) H(%) N(?é) Cl(%) beregnet: 61,31 6,17 8,17 10,34 fundet: 61,06 6,20 7,95 10,22Elemental analysis for C ^H ^N ^OgClg in C (%) H (%) N (é) Cl (%) calculated: 61.31 6.17 8.17 10.34 found: 61.06 6.20 7 , 95 10.22

Magnetisk kerneresonansspektrum (CDC1,); 3Magnetic Nuclear Resonance Spectrum (CDC1); 3

CH-CH

S (ppm) : 2,16 (6H, ^ 2,30 (6H, ' XX ) !£ H ^3 2,60 m, ^H2~S2a'N< 5 3,45 (4H, -N<^h2_0 ) 4,13 {4H, -CH2-CH2-N. )S (ppm): 2.16 (6H, 2.30 (6H, XX)! H H 3 3.60 m, H 2 O ~ S 2a'N <5 3.45 (4H, -N <^ h2_0 4.13 (4H, -CH 2 -CH 2 -N.)

5,08 (IH, XX5.08 (1H, XX

.1 7,0 - 8,2 (14H, (10H) + 2(4H) 20 142869 EKSEMPEL 10 (a) I 5 ml isopropanol opløstes 3,0 g P-chlorethylacetoacetat, 3,3 g m-nitrobenzaldehyd og 2,3 g methyl-p-aminocrotonat, og opløsningen blev opvarmet til 80°C i 4 timer.. 7.0 - 8.2 (14H, (10H) + 2 (4H) EXAMPLE 10 (a) In 5 ml of isopropanol, 3.0 g of P-chloroethyl acetoacetate, 3.3 g of m-nitrobenzaldehyde and 2, 3 g of methyl p-aminocrotonate and the solution was heated to 80 ° C for 4 hours.

Den således fremstillede reaktionsblanding blev koncentreret under formindsket tryk, remanensen opløst i en lille mængde ethylacetat, opløsningen underkastet silicagel-søjlekromatografi (diameter 3,3 cm, højde 20 cm), og produktet derpå elueret med ethylacetat. Eluater-ne indeholdende det ønskede produkt blev opsamlet og koncentreret, hvorved der blev opnået 2,0 g 2,6-dimethyl-4-(3'-nitrophenyl)-l,4-dihydropyridin-3,5-dicarboxylsyre-3-p-chlorethylester-5-methylester-The reaction mixture thus prepared was concentrated under reduced pressure, the residue dissolved in a small amount of ethyl acetate, the solution subjected to silica gel column chromatography (diameter 3.3 cm, height 20 cm), and the product then eluted with ethyl acetate. The eluents containing the desired product were collected and concentrated to give 2.0 g of 2,6-dimethyl-4- (3'-nitrophenyl) -1,4-dihydropyridine-3,5-dicarboxylic acid 3-p -chlorethylester-5-methyl ester

Smeltepunkt: 130-131°C.Melting point: 130-131 ° C.

Elementanalyse for C18H19N2C6C1: C(%) H(%) N(%) Cl(%) beregnet: 54,76 4,85 7,10 8,98 fundet: 54,43 4,74 6,91 9,18 (b) I 6 ml toluen opløstes 2,0 g 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridin-3,5-dicarboxylsyre-3-P-chlorethylester-5-methylester og 1,3 g N-methylbenzylamin, og den således dannede opløsning blev opvarmet under tilbagesvaling i 5 timer. Efter afslutning af reaktionen blev reaktionsblandingen blandet med 30 ml chloroform og 10 ml vand, og det dannede organiske lag blev skilt fra og vasket med 10 ml 10% saltsyre og derpå med vand. Den således opnåede organiske opløsning blev tørret over vandfrit magnesiumsulfat, hvorpå opløsningsmidlet blev afdestilleret under formindsket tryk. Remanensen sattes til 10 ml ethylacetat, og blandingen blev omrørt under afkøling, hvorved der krystalliserede 2,6-dimethyl-4-(3’-nitrophenyl)-1,4-dihydropyri-din-3,5'-dicarboxylsyre-3-P-(N-benzyl-N-methylamino)ethylester-5-methylester-hydrochlorid. Mængden af det således opnåede produkt var 1,6 g. Produktet havde efter omkrystallisation fra en methanol/acetone- blanding et smeltepunkt på 180-181°C.Elemental Analysis for C18 H19 N2 Cl6 Cl: C (%) H (%) N (%) Cl (%) Calcd: 54.76 4.85 7.10 8.98 Found: 54.43 4.74 6.91 9.18 (b ) In 6 ml of toluene were dissolved 2.0 g of 2,6-dimethyl-4- (3'-nitrophenyl) -1,4-dihydropyridine-3,5-dicarboxylic acid 3-β-chloroethyl ester-5-methyl ester and 1.3 g of N-methylbenzylamine and the solution thus formed was heated at reflux for 5 hours. After completion of the reaction, the reaction mixture was mixed with 30 ml of chloroform and 10 ml of water, and the organic layer formed was separated and washed with 10 ml of 10% hydrochloric acid and then with water. The organic solution thus obtained was dried over anhydrous magnesium sulfate and the solvent was distilled off under reduced pressure. The residue was added to 10 ml of ethyl acetate and the mixture was stirred under cooling to crystallize 2,6-dimethyl-4- (3'-nitrophenyl) -1,4-dihydropyridine-3,5'-dicarboxylic acid-3-P - (N-benzyl-N-methylamino) ethyl ester 5-methyl ester hydrochloride. The product thus obtained was 1.6 g. The product, after recrystallization from a methanol / acetone mixture, had a melting point of 180-181 ° C.

Elementanalyse for C26H30N3°6C1: C(%) H(%) N(%) Cl(%) beregnet: 60,52 5,86 8,14 6,87 fundet: 60,35 5,87 7,90 6,67 21 142859 (c) I 6 ml toluen opløstes 2,0 g 2,6-dimethyl-4-(3,-nitrophenyl)-l,4-dihydropyridin-3,5-dicarboxylsyre-3-P-chlorethylester-5-methylester og 1,2 g benzylamin, og opløsningen blev opvarmet under tilbagesvaling i 3 timer. Efter reaktionens afslutning blev reaktionsblandingen blandet med 30 ml chloroform og 10 ml vand, og det dannede organiske lag blev skilt fra, tørret over vandfrit magnesiumsulfat og destilleret under formindsket tryk for at fjerne opløsningsmidlet. Remanensen blev underkastet en silicagel-søjlekromatografi (diameter 4 cm, højde 25 cm), og produktet blev elueret ved anvendelse af en blanding af benzen og acetone i volumenforholdet 10:l.Eluatet indeholdende det ønskede produkt blev undersøgt ved tyndtlagskromatografi og blev opsamlet og koncentreret under formindsket tryk, hvorved der blev opnået 0,8 g krystallinsk pulver af 2,6-dimethyl-4-(3’-nitro-phenyl) -1,4-dihydropyridin-3,5-dicarboxylsyre-3- β- (N-benzylamino) ethyl-ester-5-methylester.Elemental analysis for C26H30N3 ° 6C1: C (%) H (%) N (%) Cl (%) calculated: 60.52 5.86 8.14 6.87 found: 60.35 5.87 7.90 6.67 (C) In 6 ml of toluene was dissolved 2.0 g of 2,6-dimethyl-4- (3,3-nitrophenyl) -1,4-dihydropyridine-3,5-dicarboxylic acid 3-β-chloroethyl ester-5-methyl ester and 1.2 g of benzylamine, and the solution was refluxed for 3 hours. After completion of the reaction, the reaction mixture was mixed with 30 ml of chloroform and 10 ml of water, and the resulting organic layer was separated, dried over anhydrous magnesium sulfate and distilled under reduced pressure to remove the solvent. The residue was subjected to a silica gel column chromatography (diameter 4 cm, height 25 cm) and the product was eluted using a 10: 1 volume ratio of benzene and acetone. The eluate containing the desired product was examined by thin layer chromatography and collected and concentrated. under reduced pressure to obtain 0.8 g of crystalline powder of 2,6-dimethyl-4- (3'-nitro-phenyl) -1,4-dihydropyridine-3,5-dicarboxylic acid 3- β- (N -benzylamino) ethyl ester-5-methyl ester.

Elementanalyse for ^25Η27Ν3°6: C(%) H(%) N(%) beregnet: 64,50 5,85 9,03 fundet: 64,41 5,72 8,85Elemental analysis for Η25Η27Ν3 ° 6: C (%) H (%) N (%) calculated: 64.50 5.85 9.03 Found: 64.41 5.72 8.85

Hydrochloridet af produktet, fremstillet ved behandling af dette med alkoholisk hydrogenchlorid, viste et smeltepunkt på 128-130°C (dek.).The hydrochloride of the product prepared by treating it with alcoholic hydrogen chloride showed a melting point of 128-130 ° C (dec.).

EKSEMPEL 11 (a) I 10 ml isopropanol opløstes 3,32 g acetoeddikesyre-p-chlorethyl-ester, 3,0 g m-nitrobenzaldehyd og 2,86 g P-aminocrotonsyre-isopropyl-ester, og opløsningen blev opvarmet under tilbagesvaling i 5 timer. Reaktionsblandingen blev koncentreret, og remanensen underkastet en silicagel-kromatografi. Produktet blev elueret derfra ved anvendelse af en blanding af chloroform og acetone i volumenforholdet 10:1, eluaterne indeholdene det ønskede produkt blev opsamlet, opløsningsmidlet blev afdestilleret fra opløsningen, og de således dannede krystaller blev omkrystalliseret fra en chloroform/ether-blanding, hvorved der blev opnået 2,5 g 2,6-dimethyl-4-(3'-nitrophenyl)-l,4-dihydropyridin-3,5-dicarboxylsyre-3-p-chlorethylester-5-isopropylester.EXAMPLE 11 (a) In 10 ml of isopropanol, 3.32 g of acetoacetic acid p-chloroethyl ester, 3.0 g of m-nitrobenzaldehyde and 2.86 g of β-aminocrotonic acid isopropyl ester were dissolved and the solution was heated under reflux for 5 minutes. hours. The reaction mixture was concentrated and the residue subjected to silica gel chromatography. The product was eluted therefrom using a 10: 1 volume ratio of chloroform and acetone, the eluates containing the desired product were collected, the solvent was distilled off from the solution, and the crystals thus formed were recrystallized from a chloroform / ether mixture, 2.5 g of 2,6-dimethyl-4- (3'-nitrophenyl) -1,4-dihydropyridine-3,5-dicarboxylic acid 3-p-chloroethyl ester-5-isopropyl ester were obtained.

22 14286922 142869

Smeltepunkt: 140-145°C.Melting point: 140-145 ° C.

Elementanalyse for C20H25N2°6C1:Elemental Analysis for C20H25N2 ° 6C1:

Ctø) Htø) Ntø) Cltø) beregnet: 56,81 5,48 6,62 8,38 fundet: 56,52 5,22 6,46 8,63 (b) I 6 ml toluen opløstes 2,0 g 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridin-3,5-dicarboxylsyre-3-P-chlorethylester-5-isopropyl-ester og 1,4 g N-ethylbenzylamin, og opløsningen blev opvarmet under tilbagesvaling i 5 timer. Efter afslutning af reaktionen blev reaktionsblandingen blandet med 30 ml chloroform og 10 ml vand, og det dannede organiske lag blev skilt fra, tørret over vandrit magnesiumsulfat og destilleret under formindsket tryk for at fjerne opløsningsmidlet. Remanensen blev underkastet en silicagel-søjlekromatografi (diameter 4 cm, højde 25 cm), produktet blev elueret ved anvendelse af en blanding af benzen og acetone i volumenforholdet 10:1, og eluaterne indeholdende det ønskede produkt blev opsamlet og koncentreret under formindsket tryk. Den opnåede remanens blev opløst i ethanol, og efter syrning af opløsningen med en ethanolisk opløsning af hydro-genchlorid blev opløsningen koncentreret under formindsket tryk. Ved omkrystallisation af produktet fra en chloroform/ether-blanding blev der opnået 1,1 g 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dinitropyridin- 3,5-dicarboxylsyre-3-P-(N-benzyl-N-ethylamino)ethylester-5-isopropyl-ester-hydrochlorid.Ctø) Htø) Ntø) Cltø) calculated: 56.81 5.48 6.62 8.38 found: 56.52 5.22 6.46 8.63 (b) In 6 ml of toluene dissolved 2.0 g of 2, 6-Dimethyl-4- (3'-nitrophenyl) -1,4-dihydropyridine-3,5-dicarboxylic acid 3-β-chloroethyl ester-5-isopropyl ester and 1.4 g of N-ethylbenzylamine, and the solution was heated under reflux for 5 hours. After completion of the reaction, the reaction mixture was mixed with 30 ml of chloroform and 10 ml of water, and the organic layer formed was separated, dried over anhydrous magnesium sulfate and distilled under reduced pressure to remove the solvent. The residue was subjected to a silica gel column chromatography (diameter 4 cm, height 25 cm), the product was eluted using a 10: 1 volume ratio of benzene and acetone, and the eluates containing the desired product were collected and concentrated under reduced pressure. The residue obtained was dissolved in ethanol and, after acidification of the solution with an ethanolic solution of hydrogen chloride, the solution was concentrated under reduced pressure. Recrystallization of the product from a chloroform / ether mixture yielded 1.1 g of 2,6-dimethyl-4- (3'-nitrophenyl) -1,4-dinitropyridine-3,5-dicarboxylic acid 3-β- ( N-benzyl-N-ethylamino) ethyl ester 5-isopropyl ester hydrochloride.

Smeltepunkt: 132-135°C.Melting point: 132-135 ° C.

Elementanalyse for CggH^gN^OgCl:Elemental Analysis for Cgg H

Ctø) Htø) Ntø) Cltø) beregnet: 62,41 6,50 7,53 6,35 fundet: 62,30 6,38 7,49 6,41 EKSEMPEL 12Ctø) Htø) Ntø) Cltø) calculated: 62.41 6.50 7.53 6.35 found: 62.30 6.38 7.49 6.41 Example 12

En blanding af 5,26 g acetoeddikesyre-p-(N-methyl-N-p-methylbenzyl-amino)ethylester, 2,86 g p-aminocrotonsyre-isopropylester og 3,02 g m-nitrobenzaldehyd blev omrørt i 6 timer ved 100°C på et oliebad.A mixture of 5.26 g of acetoacetic acid β- (N-methyl-Nβ-methylbenzylamino) ethyl ester, 2.86 g of p-aminocrotonic acid isopropyl ester and 3.02 g of m-nitrobenzaldehyde was stirred for 6 hours at 100 ° C. on an oil bath.

Efter afslutning af reaktionen blev reaktionsblandingen underkastet en silicagel-søjlekromatografi (diameter 4 cm, højde 25 cm), produktet 23 1Λ 2 8 8 9 blev elueret med en blanding af chloroform og acetone i volumenforhol-det 20:1, og eluaterne indeholdende det ønskede produkt blev undersøgt ved tyndtlags-kromatografi, opsamlet og koncentreret, hvorved der blev opnået 2,6-dimethyl-4-(3?-nitrophenyl)-l,4-dihydropyridin- 3,5-dicarboxylsyre-5-isopropylester-3-P-(N-methyl-N-p-methylbenzyl-amino)ethyle ster.After completion of the reaction, the reaction mixture was subjected to a silica gel column chromatography (diameter 4 cm, height 25 cm), the product 23 1Λ 2 8 8 9 was eluted with a mixture of chloroform and acetone in the 20: 1 volume ratio, and the eluates containing the desired product was examined by thin layer chromatography, collected and concentrated to give 2,6-dimethyl-4- (3-nitrophenyl) -1,4-dihydropyridine-3,5-dicarboxylic acid 5-isopropyl ester-3-P - (N-methyl-Np-methylbenzylamino) ethyl star.

Magnetisk kerneresonansspektrum (CDCl^):Nuclear Magnetic Resonance Spectrum (CDCl

HH

£ (ppm) : 1,09(3H), 1,24 (3H) < 4^" > 2.2 (3H, -N<TCH ) ^^ tli 2.3 - 2.4 (9H, h3C PCH3 * » Λ~» •'Wv 2,62 (2H, -CH^lK ) 3,47 (2H, -N-CH?~Q- ) 4,17 (2H, -CH2-CH2-N< ) 4,8 - 5,1 (IH, -CH<™3 ) ΛΜ· ^**2 5,10 (IH, |fT° ) ή 7,13 (4H, )Δ (ppm): 1.09 (3H), 1.24 (3H) <4 + "> 2.2 (3H, -N <TCH) + tl 2.3 - 2.4 (9H, h3C PCH3 *" Λ ~ »•) Wv 2.62 (2H, -CH2 -K) 3.47 (2H, -N-CH2-Q-) 4.17 (2H, -CH2-CH2-N <) 4.8 - 5.1 (1H , -CH <™ 3) ΛΜ · ^ ** 2 5.10 (1H, | fT °) ή 7.13 (4H,)

H '^'HH '^' H

ΛΛΤ h| NO, 7,2 - 8,2 (4H, * ηΑ^ΛηΛΛΤ h | NO, 7.2 - 8.2 (4H, * ηΑ + Λη)

***** I***** I

Produktet blev opløst i acetone, og efter indstilling af den fremstillede opløsning til pH 1-2 med en ethanolopløsning mættet med hydrogen-chlorid blev opløsningen koncentreret. Den dannede remanens blev oplist i en lille mængde acetone og ved tilsætning af petroleumsether til opløsningen blev der opnået 4 g pulverformet 2,6-dimethyl-4-(3’-nitrophenyl)-1,4-dihydropyridin-3,5-dicarboxylsyre-5-isopropylester- 3-P-(N-methyl-N-p-methylbenzylamino)ethylester-hydrochlorid.The product was dissolved in acetone and after adjusting the prepared solution to pH 1-2 with an ethanol solution saturated with hydrogen chloride, the solution was concentrated. The residue formed was dissolved in a small amount of acetone and by adding petroleum ether to the solution, 4 g of powdered 2,6-dimethyl-4- (3'-nitrophenyl) -1,4-dihydropyridine-3,5-dicarboxylic acid was obtained. 5-isopropyl ester 3-β- (N-methyl-Nβ-methylbenzylamino) ethyl ester hydrochloride.

Elementanalyse for C29H36N3°6C1: C(%) H(%) N(%) Cl(%) beregnet: 62,41 6,50 7,53 6,35 fundet: 62,61 6,69 7,23 6,35 EKSEMPEL 15 24 U2869Elemental analysis for C 29 H 36 N 3 ° 6 Cl: C (%) H (%) N (%) Cl (%) calculated: 62.41 6.50 7.53 6.35 found: 62.61 6.69 7.23 6.35 EXAMPLE 15 U2869

En "blanding af 5,0 g acetoeddikesyre-p-(N-methyl-N-p-methoxybenzyl-amino)ethylester, 2,4 g p-aminocrotonsyre-ethylester og 2,4 g m-nitrobenzaldehyd blev opvarmet til 85°C i 5 timer. Derefter blev der ved behandling af reaktionsblandingen som i eksempel 13 opnået 4,1 g 2,6-dimethyl-4-(3’-nitrophenyl)-1,4-dihydropyridin-3,5-dicar-boxylsyre-5-ethylester-3-P-(N-methyl-N-p-methoxybenzylamino)ethyl-ester.A mixture of 5.0 g of acetoacetic acid β- (N-methyl-Nβ-methoxybenzylamino) ethyl ester, 2.4 g of p-aminocrotonic acid ethyl ester and 2.4 g of m-nitrobenzaldehyde was heated to 85 ° C for 5 minutes. Then, by treating the reaction mixture as in Example 13, 4.1 g of 2,6-dimethyl-4- (3'-nitrophenyl) -1,4-dihydropyridine-3,5-dicarboxylic acid 5-ethyl ester were obtained. -3-P- (N-methyl-Np-methoxy-benzylamino) ethyl ester.

Elementanalyse for C28H33N3°7: C(%) H(%) N(jé) beregnet; 64,23 6,35 8,03 fundet 64,01 6,41 '7 »85Elemental analysis for C 28 H 33 N 3 ° 7: C (%) H (%) N (j) calculated; 64.23 6.35 8.03 found 64.01 6.41 '7 »85

Magnetisk kerneresonansspektrum (CDCl^): å(ppm)ϊ 1,21 (3H, -COOCH2-CH3 ) 2,20 (3H, -N< ) 2,36 (6H, XN]^ ) H3C l CE 3 /VVv\ 2,63 (2H,. -CH2-N< )' 3-,45 (2H, ) .Nuclear Magnetic Resonance Spectrum (CDCl3): δ (ppm) ϊ 1.21 (3H, -COOCH2-CH3) 2.20 (3H, -N <) 2.36 (6H, XN] +) H3C1 CE 3 / VVv 2.63 (2H, -CH2-N <) - 3-, 45 (2H,)

3,60 (3H, *-O“0CH3 > «Vv^v* 4,0 - -4-,3 (4H, -COO-CH,- ) A-h ^ 5,13 (IH, ( |)~ ) Γ 6,82 (2H) , 7,20 (2H) ( )3.60 (3H, -O + OCH 3> Vv ^ v * 4.0 - -4-, 3 (4H, -COO-CH, -) Ah ^ 5.13 (1H, (|) ~) Γ 6.82 (2H), 7.20 (2H) ()

H HH H

J-irL - m«» 7,3 - 8,2 (4H, Q)-N02 ) 25 14-2869 EKSEMPEL 14J-irL - m «7.3 - 8.2 (4H, Q) -NO₂) 14-2869 EXAMPLE 14

En blanding af 1,5 g m-nitrobenzaldehyd, 2,8 g acetoeddikesyre-p-(N-methyl-N-p-chlorbenzylamino)ethylester, 1,3 g P-aminocrotonsyre-ethylester og 5 ml ethanol blev omrørt i 3 timer ved 95°C.A mixture of 1.5 g of m-nitrobenzaldehyde, 2.8 g of acetoacetic acid β- (N-methyl-Nβ-chlorobenzylamino) ethyl ester, 1.3 g of β-aminocrotonic acid ethyl ester and 5 ml of ethanol was stirred for 3 hours at 95 ° C. ° C.

Opløsningsmidlet blev afdestilleret under formindsket tryk, remanensen underkastet en silicagel-søjlekormatografi, og produktet elueret med en benzen/acetoneblanding i volumenforholdet 10:1. Gennemløbene indeholdende det ønskede produkt blev opsamlet, og opløsningsmidlet af-destilleret. Den dannede remanens blev opløst i ethanol, og efter syrning af opløsningen med en IN ethanolisk hydrogenchloridopløsning, blev ethanolet afdestilleret under formindsket tryk. Den således dannede remanens blev opløst i en lille mængde acetone, og efter tilsætning af ether til opløsningen, indtil der dannedes uklarhed, fik opløsningen lov at henstå ved 0°C, hvorved der blev opnået 2,8 g lysegule nåleformede krystaller af 2,6-dimethyl-4-(3'-nitrophenyl)-l,4-dihydro-pyridin-3,5-dicarboxylsyre-5-ethylester-3-p-(N-methyl-N-p-chlorbenzyl-amino)ethylester-hydrochlorid.The solvent was distilled off under reduced pressure, the residue subjected to a silica gel column chromatography, and the product eluted with a benzene / acetone mixture in the volume ratio of 10: 1. The vials containing the desired product were collected and the solvent was distilled off. The residue formed was dissolved in ethanol and after acidification of the solution with 1N ethanolic hydrogen chloride solution, the ethanol was distilled off under reduced pressure. The residue thus formed was dissolved in a small amount of acetone, and after adding ether to the solution until cloudiness formed, the solution was allowed to stand at 0 ° C to give 2.8 g of pale yellow needle-shaped crystals of 2.6 dimethyl-4- (3'-nitrophenyl) -l, 4-dihydro-pyridine-3,5-dicarboxylic acid 5-ethyl ester 3-p- (N-methyl-N p-chlorobenzyl-amino) ethyl ester hydrochloride.

Smeltepunkt: 135-139°C (dekomp.).Melting point: 135-139 ° C (decomp.).

Element analyse for CElement analysis for C

C(%) H(%) N(%) Cl(%) beregnet: 57,45 5,54 7,44 12,56 fundet: 57,10 5,62 7,35 12,77 EKSEMPEL 15 I 20 ml isopropylalkohol opløstes 7,0 g acetoeddikesyre-P-(N-methyl-N-p-methoxybenzylamino)ethylester, 2,0 g m-nitrobenzaldehyd og 2,2 ml 28% ammoniakvand, og opløsningen blev omrørt i 6 timer ved 85°C. Reaktionsblandingen blev opløst i ethylacetat Og derpå ekstraheret en gang med overskydende fortyndet saltsyre og tre gange med vand. Ekstrakterne blev kombineret, og efter alkalisering af blandingen med en fortyndet vandig opløsning af natriumhydroxid blev produktet ekstraheret med chloroform. Ekstrakten blev tørret over vandfrit magnesiumsulfat, og chloroformet derpå afdestilleret under formindsket tryk. Remanensen blev underkastet en silicagel-søjlekromatografi, og produktet blev elueret til rensning med ethylacetat. Fraktionerne af det ønskede produkt blev opsamlet og koncentreret. Efter syrning af rema- 26 142869 nensen med en IN ethanolisk hydrogenchloridopløsning blev opløsningsmidlet afdestilleret under formindsket tryk, hvorved der blev opnået 5,0 g krystallinsk pulver af 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridin-5,5-dicarboxylsyre-bis/p-(N-methyl-N-p-methoxybenzyl-amino )ethyl7ester-dihydrochlorid.C (%) H (%) N (%) Cl (%) calculated: 57.45 5.54 7.44 12.56 Found: 57.10 5.62 7.35 12.77 EXAMPLE 15 In 20 ml of isopropyl alcohol was dissolved 7.0 g of acetoacetic acid P- (N-methyl-Np-methoxybenzylamino) ethyl ester, 2.0 g of m-nitrobenzaldehyde and 2.2 ml of 28% ammonia water and the solution was stirred for 6 hours at 85 ° C. The reaction mixture was dissolved in ethyl acetate and then extracted once with excess dilute hydrochloric acid and three times with water. The extracts were combined and after alkalizing the mixture with a dilute aqueous solution of sodium hydroxide, the product was extracted with chloroform. The extract was dried over anhydrous magnesium sulfate and then chloroform distilled off under reduced pressure. The residue was subjected to a silica gel column chromatography and the product was eluted to purify with ethyl acetate. The fractions of the desired product were collected and concentrated. After acidification of the residue with 1N ethanolic hydrogen chloride solution, the solvent was distilled off under reduced pressure to give 5.0 g of crystalline powder of 2,6-dimethyl-4- (3'-nitrophenyl) -1,4-amine. dihydropyridine-5,5-dicarboxylic acid bis / β- (N-methyl-Nβ-methoxybenzylamino) ethyl ester dihydrochloride.

Elementanalyse for C^H^gN^OgCl^: C(%) H(J6) N(%) Cl(%) beregnet: 59,60 6,22 7,51 9,51 . ftindet: 59,55 6,03 7,79 9,69Elemental analysis for C ^H ^ gNNO OgClCl: C (%) H (J6) N (%) Cl (%) calculated: 59.60 6.22 7.51 9.51. Found: 59.55 6.03 7.79 9.69

Magnetisk kerneresonansspektum (DMSD-dg): S (ppm): 2,36 (6H, jLj^ ) H ^ 2,64 (6H, -N<^3 ) 3,38 (4H, -CH2-N\CH3 ) ΛΛνν 3/80 (6H, ) 4,30 (4H, -N<CH_^y ) 4,44 (4H, -C00CH2- ) 5,08 (1H' fV-a )Nuclear Magnetic Resonance Spectrum (DMSD-dg): S (ppm): 2.36 (6H, jLj ^) H ^ 2.64 (6H, -N <^ 3) 3.38 (4H, -CH2-N \ CH3) ΛΛνν 3/80 (6H,) 4.30 (4H, -N <CH 2 γ) 4.44 (4H, -C00CH 2 -) 5.08 (1H 'fV-a)

Sk 7,0 - 8,2 (12H, (8H) + 2 (4H) ) EKSEMPEL 16 I 3 ml isopropylalkohol opløstes 1,6 g o-trifluormethylbenzaldehyd, 1,6 g 3-aminocrotonsyre-P-(N-benzyl-N-ethylamin)ethylester og 0,9 g acetoeddikesyre-propoxyethylester, hvorpå opløsningen blev omrørt i 14 timer ved 85°C. Reaktionsblandingen blev koncentreret, remanensen opløst; i en lille mængde chloroform/aceton-blanding i volumenforholdet 20 : 1, og derpå blev opløsningen underkastet silicagel-søjlekromatografi (diameter 3,5 cm, højde 20 cm). Produktet blev elueret med en chloroform/acetone-blanding i volumenforholdet 20 : 1, 27 142869 og eluaterne indeholdende del ønskede produkt blev undersøgt ved tyndtlagschromatografi, opsamlet og koncentreret, hvorved der blev opnået Ο,β g 4-(2-trlfluormethylphenyl)-2,6-dimethyl-l,4-di-hydropyr idin-3,5-dicarboxylsyre-3- β- (N-benzyl-Τί- e thylamino) ethyl-ester-S^-propQjryethylester.Sk 7.0 - 8.2 (12H, (8H) + 2 (4H)) EXAMPLE 16 In 3 ml of isopropyl alcohol was dissolved 1.6 g of o-trifluoromethylbenzaldehyde, 1.6 g of 3-aminocrotonic acid P- (N-benzyl). N-ethylamine) ethyl ester and 0.9 g of acetoacetic acid propoxyethyl ester, whereupon the solution was stirred for 14 hours at 85 ° C. The reaction mixture was concentrated, the residue dissolved; in a small amount of chloroform / acetone mixture in a 20: 1 volume ratio, and then the solution was subjected to silica gel column chromatography (diameter 3.5 cm, height 20 cm). The product was eluted with a chloroform / acetone mixture in 20: 1, 27 142869 volume ratio and the eluates containing part desired product were assayed by thin layer chromatography, collected and concentrated to give Ο, β g of 4- (2-trifluoromethylphenyl) -2 , 6-Dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid 3- β- (N-benzyl-δί-thylamino) ethyl ester-S--propylethyl ester.

Elementanalyse for G3^9N205F3: C(%) H(9é) N(%) beregnet: 65,23 6,68 4,76 fundet: 65,37 6,89 4,82Elemental analysis for G3 9N2 O5 F3: C (%) H (9e) N (%) calculated: 65.23 6.68 4.76 found: 65.37 6.89 4.82

Magnetisk kerneresonanp spektrum (CDCl^): i (ppm); 0,84 (39, -CJ^CI^-CH^ ) 0,96 (3H, ) 1,52 (2H, -0-CH2-CH2-CH3 )Nuclear Magnetic Resonance Spectrum (CDCl3): i (ppm); 0.84 (39, -CJ 2 Cl 2 -CH 2) 0.96 (3H,) 1.52 (2H, -0-CH 2 -CH 2 -CH 3)

1 eAW1 eAW

2,26 (6H, XX ) as · ^3 2,46 (2H, -0^-9^2^3 ) 2,63 (2H, -CH2-CH2-HCCH2CH3 ) WVv ‘ 3,31 (2H), 3,58 (2H) (-H2C-0-CH2- ) 3,57 (2H, -N<CH2_0 ) 4.0 - 4,2 (4H, -C00-CH2- ) 5,55 (IH, θ'- · ) 7.1 - 7,6 (9H, -0 (5H) + {Qf 2 (4H) EKSEMPEL· 17 .....I1 2 3 4 H 1 1 " 3 ml isopropylalkohol opløstes 1,07 g acetoeddikesyre-r5-(N-methyl- 2 N-p-methylbenzylamino)ethylester, 0,466 g β-aminocrotonsyre-methyl- 3 ester og 0,7Q5 g m-trifluormethylbenzaldehyd, og opløsningen blev opvarmet under tilbagesvaling i 6 timer. Reaktionsblandingen blev koncentreret, underkastet silicagel-søjlechrometografi (diameter 4 cm, højde 15 cm), og eluaterne indeholdende det ønskede produkt blev opsamlet og koncentreret. Den således opnåede remanens blev opløst i acetone, og efter indstilling af opløsningens pH-vserdi til 1-2 med en ethanolopløsning mættet med hydrogenchlorid 28 142869 blev opløsningen koncentreret. Ved krystallisation af den dannede remanens fra acetone blev der opnået 0,8 g 2,6-dimethyl-'4—(3'-tri-f luormethylphenyl) -1,4-dihydropyridin-3,5-dicarboxylsyr e-5-methyl-e ster-3- β- (K-methyl-N-p-methylbenzylamino) ethyle st er-hydrochlorid Smeltepunkt: 130 - 132° C.2.26 (6H, XX) as · 3.34 2.46 (2H, -O ^ -9 ^ 2 ^ 3) 2.63 (2H, -CH2-CH2-HCCH2CH3) WVv '3.31 (2H), 3.58 (2H) (-H2C-O-CH2-) 3.57 (2H, -N <CH2_0) 4.0 - 4.2 (4H, -C00-CH2-) 5.55 (1H, θ'- · ) 7.1 - 7.6 (9H, -0 (5H) + {Qf 2 (4H) EXAMPLE · 17 ..... I1 2 3 4 H 1 1 "3 ml of isopropyl alcohol was dissolved 1.07 g of acetic acetic acid r5- ( N-methyl-2 Nβ-methylbenzylamino) ethyl ester, 0.466 g of β-aminocrotonic acid methyl ester and 0.7Q5 g of m-trifluoromethylbenzaldehyde, and the solution was heated at reflux for 6 hours. 4 cm, height 15 cm) and the eluates containing the desired product were collected and concentrated The residue thus obtained was dissolved in acetone and, after adjusting the pH of the solution to 1-2 with an ethanol solution saturated with hydrogen chloride 28, the solution On crystallization of the residue formed from acetone, 0.8 g of 2,6-dimethyl-4- (3'-trifluoromethyl) was obtained. lphenyl) -1,4-dihydropyridine-3,5-dicarboxylic acid e-5-methylester ester 3- β- (K-methyl-N-p-methylbenzylamino) ethyl st hydrochloride Melting point: 130-132 ° C.

Elementanalyse for C28H32N2°4F3C1: C(9fi) H(%) Ntø) Cltø) beregnet: 60,81 5,83 5,07 6,41 fundet: 61*11 6,01 5,35 6,67 EKSEMPEL 18Elemental Analysis for C28H32N2 ° 4F3C1: C (9fi) H (%) Nt0) Clt0) calculated: 60.81 5.83 5.07 6.41 found: 61 * 11 6.01 5.35 6.67 Example 18

En blanding af 1 g acetylacetone, 0,75 ml koncentreret ammoniakvand, 1,5 g m-nitrobenzaldehyd, 2,5 g acetoeddikesyre-β-(N-benzyl-N-methyl-amino)ethylester og 5 ml ethanol blev opvarmet til 90°C i 4 timer. Efet afdestillering af opløsningsmidlet fra reaktionsblandingen under formindsket tryk blev remanensen opløst i 10 ml ethylacetat, og produktet extraheret med 2 N saltsyre. Extrakten blev neutraliseret med natriumcarbonat, og produktet derpå extraheret med ethylacetat. Opløsningsmidlet blev afdestilléret fra extrakten under formindsket tryk, og den dannede remanens opløst i 3 ml ethanol. Efter syrning af opløsningen med 2N ethanolisk hydrogenchlorid-opløsning sattes ethylacetat til opløsningen, indtil den blev uklar, og derpå fik opløsningen lov at henstå i 20 timer ved 0°C, hvorved der blev opnået 1,4 g gule nåleformede krystaller af 5-acetyl-2,6-dimethyl- 4-(3’-nitrophenyl)-1,4-dihydropyridin-3-carboxylsyre-β-(N-benzyl-N-methylamino)ethylester-hydrochlorid.A mixture of 1 g of acetylacetone, 0.75 ml of concentrated ammonia water, 1.5 g of m-nitrobenzaldehyde, 2.5 g of acetoacetic acid β- (N-benzyl-N-methylamino) ethyl ester and 5 ml of ethanol was heated to 90 ° C for 4 hours. After distilling off the solvent from the reaction mixture under reduced pressure, the residue was dissolved in 10 ml of ethyl acetate and the product extracted with 2N hydrochloric acid. The extract was neutralized with sodium carbonate and the product then extracted with ethyl acetate. The solvent was distilled off from the extract under reduced pressure and the resulting residue dissolved in 3 ml of ethanol. After acidification of the solution with 2N ethanolic hydrogen chloride solution, ethyl acetate was added to the solution until it became cloudy and then allowed to stand for 20 hours at 0 ° C to give 1.4 g of yellow needle-shaped crystals of 5-acetyl -2,6-dimethyl-4- (3'-nitrophenyl) -1,4-dihydropyridine-3-carboxylic acid β- (N-benzyl-N-methylamino) ethyl ester hydrochloride.

Smeltepunkt: 154 - 157°C (decomp.)*Melting point: 154 - 157 ° C (decomp.) *

Elementanalyse for CggH^øN^O^Cl: C(9é) Htø) Ntø) Cltø) beregnet: 62,46 6,05 8,40 7,09 fundet: 62,75 6,21 8,22 6,99 EKSEMPEL 19Elemental Analysis for CggHH ^ øN ^O ^Cl: C (9e) Htø) Ntø) Cltø) calculated: 62.46 6.05 8.40 7.09 Found: 62.75 6.21 8.22 6.99 Example 19

Til 1 g acetylacetone sattes 0,75 ml koncentreret ammoniakvand og 5 ml ethanol, og blandingen blev omrørt i 30 minutter ved stuetemperatur, hvorved der dannedes krystaller. Til produktet- sattes 29 142869 1,5 g m-nitrobenzaldehyd og 2,8 g acetoeddikesyre-P-(N-p-chlorbenzyl-N-methyl)ethylester, og blandingen blev opvarmet til 95°C 1 4 timer. Derefter blev opløsningsmidlet afdestilleret fra reaktionsblandingen under formindsket tryk, og remanensen blev underkastet silicagel-søjle-chromatografi. Fraktionerne indeholdende det ønskede produkt blev elueret med en benzen/acetone-blanding i volumenforholdet 10 : 1, eluaterne blev opsamlet, og opløsningsmidlet afdestilleret under formindsket tryk. Remanensen opløstes i ethanol, og efter syrning af opløsningen med 2N ethanolisk hydrogenchloridopløsning sattes ethylacetat til opløsningen, indtil den blev uklar. Derefter fik opløsningen lov at henstå i 3 dage ved 0°C, hvorved der blev opnået 1,2 g gule nåleformede krystaller af S-acetyl-Z^-dimethyl-^-^’-nitrophenyl)-1,4-dihydropyridin-3-carboxylsyre-β-(N-p-chlorbenzyl-N-methylamino)ethylester-hydrochlorid.To 1 g of acetylacetone was added 0.75 ml of concentrated ammonia water and 5 ml of ethanol and the mixture was stirred for 30 minutes at room temperature to give crystals. To the product was added 1.5 g of m-nitrobenzaldehyde and 2.8 g of acetoacetic acid P- (N-p-chlorobenzyl-N-methyl) ethyl ester, and the mixture was heated to 95 ° C for 4 hours. Then, the solvent was distilled off from the reaction mixture under reduced pressure and the residue was subjected to silica gel column chromatography. The fractions containing the desired product were eluted with a benzene / acetone mixture in a volume ratio of 10: 1, the eluates were collected and the solvent was distilled off under reduced pressure. The residue was dissolved in ethanol and after acidification of the solution with 2N ethanolic hydrogen chloride solution, ethyl acetate was added to the solution until it became cloudy. Then, the solution was allowed to stand for 3 days at 0 ° C to give 1.2 g of yellow needle-shaped crystals of S-acetyl-Z (dimethyl-β-N-nitrophenyl) -1,4-dihydropyridine-3 -carboxylic acid-β- (N p-chlorobenzyl-N-methylamino) ethyl ester hydrochloride.

Smeltepunkt: 145 - 150°C (decomp.).Melting point: 145-150 ° C (decomp.).

Elementanalyse for C26H29N3°5C1; C(#) H(%) N(%) Cl(%) beregnet: 58,43 5,47 7,86 13,27 fundet: 58,65 5,59 7,68 13,10 EKSEMPEL 20 I 15 ml isopropanol opløstes 5,0 g β-aminocrotonsyre-N-benzyl-N-methylaminoethylester, 3,1 g m-nitrobénzaldehyd og 2,0 g acetylacetone, og derpå blev opløsningen omrørt i 4 timer ved 85°C. Reaktionsblandingen blev opløst i 40 ml ethylacetat, og produktet extraheret med overskud af fortyndet saltsyre og yderligere tre gange med hver gang 40 ml vand. De vandige extrakter blev kombineret, og der opløstes 10 g natriumchlorid i extrakten. Det således dannede olieagtige materiale blev extraheret fire gange, hver gang med 50 ml chloroform. Chloroformextrakterne blev kombineret, tørret over vandfrit magnesiumsulfat, og chloroformet afdestilleret under formindsket tryk. Remanensen blev opløst i acetone, og derpå sattes ethylacetat til opløsningen, hvorpå der blev opnået 5,0 g gule nåleformede krystaller af 5-acetyl-2,6-dimethyl-4-(3f-nitrophenyl)-1,4-dihydropyridin-3-carboxylsyre-P-(N-benzyl-N-methylamino)ethylester-hydrochlorid.Elemental Analysis for C26H29N3 ° 5C1; C (#) H (%) N (%) Cl (%) calculated: 58.43 5.47 7.86 13.27 Found: 58.65 5.59 7.68 13.10 EXAMPLE 20 In 15 ml of isopropanol Dissolve 5.0 g of β-aminocrotonic acid N-benzyl-N-methylaminoethyl ester, 3.1 g of m-nitrobenzaldehyde and 2.0 g of acetylacetone, and then the solution is stirred for 4 hours at 85 ° C. The reaction mixture was dissolved in 40 ml of ethyl acetate and the product extracted with excess dilute hydrochloric acid and an additional three times with 40 ml of water each time. The aqueous extracts were combined and 10 g of sodium chloride was dissolved in the extract. The oily material thus formed was extracted four times, each time with 50 ml of chloroform. The chloroform extracts were combined, dried over anhydrous magnesium sulfate, and the chloroform distilled off under reduced pressure. The residue was dissolved in acetone and then ethyl acetate was added to the solution to give 5.0 g of yellow needle-shaped crystals of 5-acetyl-2,6-dimethyl-4- (3-nitrophenyl) -1,4-dihydropyridine-3 -carboxylic acid P- (N-benzyl-N-methylamino) ethyl ester hydrochloride.

Smeltepunkt: 154 - 157°C (decomp.).Melting point: 154 - 157 ° C (decomp.).

EKSEMPEL 21 30 142869 I 20 ml isopropylalkohol opløstes 2,9 g 2-amino-2-penten-4-on, 4,41 g m-nitrobenzaldehyd og 7,7 g acetoeddikesyre-P-(N-benzyl-N-methylamino)ethylester, og derpå blev opløsningen opvarmet under tilbagesvaling i 6 timer. Til reaktionsblandingen sattes 70 ml ethylacetat, og efter indstilling af opløsningens pH-værdi til 1-2 med 2N saltsyre blev det dannede vandige lag fraskilt. Ethyl-acetatlaget blev extraheret to gange med vand. De vandige lag blev kombineret, og efter mætning af opløsningen med natriumchlorid blev produktet extraheret to gange med chloroform. Chloroformextrakterne blev kombineret og tørret over vandfrit magnesiumsulfat og koncentreret. Når der sattes en lille mængde ethanol til koncentratet, dannedes krystaller, som blev udvundet ved filtrering og omkrystalliseret fra ethanol, hvorved der blev opnået 7 g 5-acetyl-2,6-dimethyl- 4-(3’-nitrophenyl)-1,4-dihydropyridin-3-carboxylsyre-p-(N-benzyl-N-methylamino)ethylester-hydrochlorid.EXAMPLE 21 In 20 ml of isopropyl alcohol were dissolved 2.9 g of 2-amino-2-penten-4-one, 4.41 g of m-nitrobenzaldehyde and 7.7 g of acetoacetic acid P- (N-benzyl-N-methylamino) ethyl ester, and then the solution was heated at reflux for 6 hours. To the reaction mixture was added 70 ml of ethyl acetate and, after adjusting the pH of the solution to 1-2 with 2N hydrochloric acid, the aqueous layer formed was separated. The ethyl acetate layer was extracted twice with water. The aqueous layers were combined and, after saturating the solution with sodium chloride, the product was extracted twice with chloroform. The chloroform extracts were combined and dried over anhydrous magnesium sulfate and concentrated. When a small amount of ethanol was added to the concentrate, crystals formed which were obtained by filtration and recrystallized from ethanol to give 7 g of 5-acetyl-2,6-dimethyl-4- (3'-nitrophenyl) -1 4-dihydropyridine-3-carboxylic acid p- (N-benzyl-N-methylamino) ethyl ester hydrochloride.

Smeltepunkt: 147 - 152°C (decomp.).Melting point: 147 - 152 ° C (decomp.).

Elementanalyse for Ο^^Η^^Ν^Ο^ΟΙ.C2H^0H: C tø) Htø) Ntø) Cltø) beregnet: 61,77 6,62 7,67 6,79 fundet: 61,59 6,65 7,70 6,49 EKSEMPEL 22 I 3 ml isopropanol opløstes 1,18 g acetoeddikesyre-N-benzyl-N-methyl-aminoethylester, 0,48 g 2-amino-2-penten-4-on og 0,83 g m-trifluor-methylbenzaldehyd, og derpå blev opløsningen opvarmet under tilbage-svaling i 6 timer. Reaktionsblandingen blev koncentreret, og remanensen underkastet silicagel-søjlechromatografi (dimater 4 cm, højde 15 cm). Produktet blev elueret med en chloroform/acetone-blanding i volumenforholdet 20 : 1, eluaterne indeholdende det ønskede produkt blev undersøgt ved tyndtlagschromatografi, opsamlet og koncentreret. Den dannede remanens blev opløst i acetone, og efter indstilling af opløsningens pH-værdi til 1-2 med en ethanolopløsning mættet med hydrogenchlorid blev opløsningen koncentreret. De dannede krystaller blev omkrystalliseret fra acetone, hvorved der blev opnået 1,3 g 5-acetyl-2,6-dimethyl-4-(3trifluormethylphenyl)-1,4-dihy dr opyr idin- 3-c arb oxy 1 syr e - β - (N-b enzy 1-N-me thyl amino) ethylester-hydrochlorid .Elemental Analysis for Ο ^^ Η ^^ Ν ^ Ο ^ ΟΙ.C2H ^ 0H: C th) Htø) Ntø) Cltø) calculated: 61.77 6.62 7.67 6.79 found: 61.59 6.65 7 Example 6.4 In 3 ml of isopropanol was dissolved 1.18 g of acetoacetic acid N-benzyl-N-methylaminoethyl ester, 0.48 g of 2-amino-2-penten-4-one and 0.83 g of m.p. trifluoro-methylbenzaldehyde, and then the solution was heated under reflux for 6 hours. The reaction mixture was concentrated and the residue subjected to silica gel column chromatography (dimensions 4 cm, height 15 cm). The product was eluted with a chloroform / acetone mixture in a 20: 1 volume ratio, the eluates containing the desired product were examined by thin layer chromatography, collected and concentrated. The residue formed was dissolved in acetone and, after adjusting the pH of the solution to 1-2 with an ethanol solution saturated with hydrogen chloride, the solution was concentrated. The crystals formed were recrystallized from acetone to give 1.3 g of 5-acetyl-2,6-dimethyl-4- (3trifluoromethylphenyl) -1,4-dihydro-idin-3-c arb oxy 1 acid e - β - (Nb enzyme 1-N-methylethyl) ethyl ester hydrochloride.

31 14286931 142869

Smeltepunkt: 168 - 169°C (decomp.).Melting point: 168 - 169 ° C (decomp.).

Element analyse for £{%) H(tf) N(%) Cl(%) beregnet: 62,01 5,78 5,36 6,78 fundet: 62,30 5,90 5,33 6,95 EKSEMPEL 25Elemental Analysis for (%) H (tf) N (%) Cl (%) Calcd: 62.01 5.78 5.36 6.78 Found: 62.30 5.90 5.33 6.95 Example 25

En blanding af 1,0 g o-trifluormethylbenzaldehyd, 1,6 g actoeddike-syre-β-(N-benzyl-N-methylamino)ethylester og 700 mg β-aminocroton-syre-methylester omrørtes i 6 timer ved 110 - 120°C. Reaktionsblandingen opløstes i en lille mængde chloroform/acetone-blanding i volumenforholdet 20 : 1, og derpå blev opløsningen underkastet silicagel-søjlechromatografi (diameter 3,5 cm, højde 20 cm). Produktet blev elueret med en chloroform/acetone-blanding i volumenforholdet 20 : 1, og eluateme indeholdende det ønskede produkt blev undersøgt ved tyndtlagschromatografi, opsamlet og koncentreret. Remanensen opløstes i en lille mængde acetone, og efter syrning af opløsningen med en ethanolopløsning mættet med hydrogenchlo-rid blev opløsningen koncentreret. Den opnåede remanens blev krystalliseret fra en acetone/ether-blanding, hvorved der blev opnået 0,7 g 2,6-dimethyl-4-(o-trifluormethylphenyl)-1,4-dihydropyridin-3,5-di-carboxylsyre-3-^-(N-benzyl-N-methylamino)ethylester-5-methylester-hydrochlorid.A mixture of 1.0 g of o-trifluoromethylbenzaldehyde, 1.6 g of actoacetic acid β- (N-benzyl-N-methylamino) ethyl ester and 700 mg of β-aminocrotonic acid methyl ester was stirred at 110-120 ° for 6 hours. C. The reaction mixture was dissolved in a small amount of chloroform / acetone mixture in a 20: 1 volume ratio and then the solution was subjected to silica gel column chromatography (diameter 3.5 cm, height 20 cm). The product was eluted with a chloroform / acetone mixture in a 20: 1 volume ratio and the eluates containing the desired product were examined by thin layer chromatography, collected and concentrated. The residue was dissolved in a small amount of acetone and after acidification of the solution with an ethanol solution saturated with hydrogen chloride, the solution was concentrated. The residue obtained was crystallized from an acetone / ether mixture to give 0.7 g of 2,6-dimethyl-4- (o-trifluoromethylphenyl) -1,4-dihydropyridine-3,5-di-carboxylic acid-3 - ^ - (N-benzyl-N-methylamino) ethyl ester 5-methyl ester hydrochloride.

Smeltepunkt: 182 - 192°C.Melting point: 182 - 192 ° C.

Elementanalyse for C^H^qI^O^F^CI : C(9é) H(%) N(%) Cl(%) beregnet 60,17 5,61 5,20 6,58 fundet: 59,93 5,86 5,48 6,90 EKSEMPEL 24 I 3 ml isopropylalkohol opløstes 1,18 g acetoeddikesyre-β-(N-benzyl-N-methylamino) ethylester, 0,55 g β-aminocrotonsyre-methylester og 0,3 g m-trifluormethylbenzaldehyd, og opløsningen blev opvarmet vinder tilbagesvaling i 6 timer. Reaktionsblandingen blev koncentreret, og remanensen underkastet silicagel-søjlechromatografi (diameter 4 cm, højde 15 cm). Produktet blev derpå elueret med en chloro- 32 142869 form/acetone-blanding I volumenforholdet 20 : 1, og eluaterne indeholdende det ønskede produkt blev undersøgt ved tyndtlagschromatografi, opsamlet og koncentreret. Den dannede remanens blev opløst i acetone, og efter indstilling af opløsningen pH-værdi til 1-2 med en ethanol-opløsning mættet med hydrogenchlorid blev opløsningen koncentreret.Elemental analysis for C ^H ^ qIIO ^F ^Cl: C (9e) H (%) N (%) Cl (%) calculated 60.17 5.61 5.20 6.58 found: 59.93 5, EXAMPLE 24 In 3 ml of isopropyl alcohol, 1.18 g of acetoacetic acid β- (N-benzyl-N-methylamino) ethyl ester, 0.55 g of β-aminocrotonic acid methyl ester and 0.3 g of m-trifluoromethylbenzaldehyde were dissolved. and the solution was heated to reflux for 6 hours. The reaction mixture was concentrated and the residue subjected to silica gel column chromatography (diameter 4 cm, height 15 cm). The product was then eluted with a chloroform / acetone mixture in 20: 1 v / v ratio, and the eluates containing the desired product were examined by thin layer chromatography, collected and concentrated. The residue formed was dissolved in acetone and, after adjusting the solution pH to 1-2 with an ethanol solution saturated with hydrogen chloride, the solution was concentrated.

Ved krystallisation af den dannede remanens fra ethylacetat blev der opnået 1,3 g -2,6-dimethyl-4-(m-trifluormethylphenyl)-1,4-dihydro-pyridin-3,5-dicarboxylsyre-3-P-(N-benzyl-N-methylamino) ethylester- 5-methylester-hydrochlorid.By crystallization of the residue formed from ethyl acetate, 1.3 g of -2,6-dimethyl-4- (m-trifluoromethylphenyl) -1,4-dihydro-pyridine-3,5-dicarboxylic acid 3-β- (N -benzyl-N-methylamino) ethyl ester 5-methyl ester hydrochloride.

Smeltepunkt: 142 - 152°C (decomp.).Melting point: 142 - 152 ° C (decomp.).

Elementanalyse for C^yH^N^O^F^Cl: C(%) H(%) N(%) Cl(%) beregnet: 60,17 5,6l 5,20 6,58 fundet: 60,47 5,63 5,49 6,71 EKSEMPET. 25 I 3 ml isopropylalkohol opløstes 1,07 g acetoeddikesyre-tf-(N-benzyl-N-methylamino)propylester, 0,52 g β-aminocrotonsyre-ethylester og 0,71 g m-trifluormethylbenzaldehyd, og opløsningen blev opvarmet under tilbagesvaling i 6 timer.Elemental analysis for C ^ yHHN NO ^F ^Cl: C (%) H (%) N (%) Cl (%) calculated: 60.17 5.6l 5.20 6.58 found: 60.47 5 , 63 5.49 6.71 EXAMPLE. In 3 ml of isopropyl alcohol, 1.07 g of acetoacetic acid tf- (N-benzyl-N-methylamino) propyl ester, 0.52 g of β-aminocrotonic acid ethyl ester and 0.71 g of m-trifluoromethylbenzaldehyde were dissolved and the solution was heated under reflux. 6 hours.

Derpå blev reaktionsblandingen ligesom i eksempel 25 underkastet silicagel-søjlekromatografi, og eluaterne indeholdende det ønskede produkt blev opsamlet og koncentreret, hvorved der blev opnået 0,9 g 2,6 dimethyl-4-(m-trifluormethylphenyl)-l,4-dihydro-pyridin-3,5-dicarboxylsyre-3-T -(N-benzyl-N-methylamino)propylester- 5-ethylester.Then, as in Example 25, the reaction mixture was subjected to silica gel column chromatography and the eluates containing the desired product were collected and concentrated to give 0.9 g of 2.6 dimethyl-4- (m-trifluoromethylphenyl) -1,4-dihydro-4 pyridine-3,5-dicarboxylic acid 3-T - (N-benzyl-N-methylamino) propyl ester 5-ethyl ester.

Element analyse for : C(%) H(%) N(%) beregnet: 65,65 6,27 5,28 fundet: 65,45 6,40 5,40Elemental analysis for: C (%) H (%) N (%) calculated: 65.65 6.27 5.28 found: 65.45 6.40 5.40

Magnetisk kerneresonansspektrum (CDCl^): S (ppm) : 1,2 (3H, -CH--CH ) '1,79 (2H, -CH2CH2CH2- )Nuclear Magnetic Resonance Spectrum (CDCl3): S (ppm): 1.2 (3H, -CH - CH) 1.79 (2H, -CH2CH2CH2-)

s****»» JLs **** »» JL

2,20 - 2,40 (6H, (fjl ) ; H3céCH3 2,12 (3Hr -N<^ch )2.20 - 2.40 (6H, (µl); H3cechCH3 2.12 (3Hr -N

-w~L-w ~ L

2,0-2,5 (2H, -CH2-CH2-N< ) A««W\ 3,42 (2H, -CH2-£^) 33 142869 3,9 - 4,3 (4H, -CH2CH3 + -CH2CH2CH2-N< ) 5,1 (IH, 0"^ ')' ',.7'1 -7-6 (9H- +ηΨΓ3 _ (5H) (4H) EKSEMPEL 26 v2.0-2.5 (2H, -CH 2 -CH 2 -N <) λ W = 3.42 (2H, -CH 2 - +) 33 3.9 - 4.3 (4H, -CH 2 CH -CH2CH2CH2-N <) 5.1 (1H, 0 "^ ')' ', .7'1 -7-6 (9H- + ηΨΓ3 _ (5H) (4H) EXAMPLE 26 v

En blanding af 1,5 g 2-(3'-nitrobenzyliden)acetoeddikesyre-P-(N-benzyl-N-methylamino)ethylester, 0,452 g β-aminocrotonsyre-methyl-ester og 7 ml isopropylalkohol blev opvarmet under tilbagesvaling i 6 timer vinder omrøring. Efter afkøling blev reaktionsblandingen blandet med 30 ml chloroform og derpå med 10 ml 2 N saltsyre. Blandingen blev rystet i en skilletragt, vasket to gange med vand, og det dannede chloroformlag skilt fra. Det således opnåede chloroform-lag blev koncentreret, og efter tilsætning af 7 ml ethylacetat til den dannede remanens blev blandingen omrørt natten over, hvorved der blev opnået 1,4 g krystaller. Krystallerne blev opløst i methanol, og efter afdestillering af opløsningsmidlet fra opløsningen blev remanensen omkrystalliseret fra acetone, hvorved der blev opnået 0,98 g 2,6-dimethyl-4-(3’-nitrophenyl)-l,4-dihydropyridin- 3,5-dicarboxylsyre-3-P- (N-benzyl-N-methylamino )ethylester-5-methyl-e ster-hydrochlorid.A mixture of 1.5 g of 2- (3'-nitrobenzylidene) acetoacetic acid P- (N-benzyl-N-methylamino) ethyl ester, 0.452 g of β-aminocrotonic acid methyl ester and 7 ml of isopropyl alcohol was heated at reflux for 6 hours. wins stirring. After cooling, the reaction mixture was mixed with 30 ml of chloroform and then with 10 ml of 2N hydrochloric acid. The mixture was shaken in a separatory funnel, washed twice with water and the resulting chloroform layer separated. The chloroform layer thus obtained was concentrated, and after adding 7 ml of ethyl acetate to the residue formed, the mixture was stirred overnight to give 1.4 g of crystals. The crystals were dissolved in methanol and, after distilling off the solvent from the solution, the residue was recrystallized from acetone to give 0.98 g of 2,6-dimethyl-4- (3'-nitrophenyl) -1,4-dihydropyridine-3, 5-dicarboxylic acid 3-β- (N-benzyl-N-methylamino) ethyl ester-5-methyl ester hydrochloride.

Smeltepunkt: 180 - 181°C.Melting point: 180 - 181 ° C.

Elementanalyse for c26H3oN3°6C1: C(%) E(%) N(%) Cl(%) beregnet: 60,52 5,86 8,14 6,87 fundet: 60,76 5,72 8,04 7,00 EKSEMPEL 27Elemental analysis for c26 H30 N3 ° 6Cl: C (%) E (%) N (%) Cl (%) calculated: 60.52 5.86 8.14 6.87 found: 60.76 5.72 8.04 7.00 EXAMPLE 27

En blanding af 1,1 g 2-(3’-nitrobenzyliden)acetoeddikesyre-p-(N-benzyl-N-methylamino)ethylester, 0,34 g acetoeddikesyre-methylester, 5 ml ethanol og 0,35 ml ammoniakvand blev opvarmet under tilbagesvaling i 5 timer under omrøring. Efter afdestillering af opløsningsmidlet blev reaktionsblandingen behandlet på samme måde som i eksempel 27, hvorved der blev opnået 0,33 g 2,6-dimethyl-4-(3'-nitrophenyl )-l ,4-dihydropyridin-3,5-dicarboxylsyre-3-P-(N-benzyl-N-methylamino )-ethylester-5-methylester-hydrochlorld,smp. 180-181°C.A mixture of 1.1 g of 2- (3'-nitrobenzylidene) acetoacetic acid β- (N-benzyl-N-methylamino) ethyl ester, 0.34 g of acetoacetic acid methyl ester, 5 ml of ethanol and 0.35 ml of ammonia water was heated under reflux for 5 hours with stirring. After distilling off the solvent, the reaction mixture was treated in the same manner as in Example 27 to give 0.33 g of 2,6-dimethyl-4- (3'-nitrophenyl) -1,4-dihydropyridine-3,5-dicarboxylic acid. 3-β- (N-benzyl-N-methylamino) ethyl ester-5-methyl ester hydrochloride, m.p. 180-181 ° C.

34 14285934 142859

Dette produkts infrarøde absorptionsspektrum stemte overens med spektret for det produkt, som blev fremstillet i eksempel 27· EKSEMPEL 28The infrared absorption spectrum of this product was consistent with that of the product prepared in Example 27 · EXAMPLE 28

En blanding af 2,49 g 2-(3,-nitrobenzyliden)acetoeddikesyre-methyl-ester, 2,48 g p-aminocrotonsyre-p-(W-benzyl-N-methylamino)ethylester og 8 ml isopropylalkohol blev opvarmet under tilbagesvaling i 6 timer under omrøring. Efter afkøling blev reaktionsblandingen blandet med 100 ml chloroform til opløsning af produktet og vasket med 2 N saltsyre til indstilling af det vandige lags pH-værdi til 1-2.A mixture of 2.49 g of 2- (3-nitrobenzylidene) acetoacetic acid methyl ester, 2.48 g of p-aminocrotonic acid p- (W-benzyl-N-methylamino) ethyl ester and 8 ml of isopropyl alcohol was heated at reflux in 6 hours with stirring. After cooling, the reaction mixture was mixed with 100 ml of chloroform to dissolve the product and washed with 2N hydrochloric acid to adjust the pH of the aqueous layer to 1-2.

Derpå blev chloroformopløsningen vasket to gange med vand, tørret over vandfrit natriumsulfat og koncentreret. Den dannede remanens blev blandet med 20 ml ethylacetat, hvorved der blev opnået 3,3 g krystaller. Krystallerne blev opløst i methanol, og opløsningsmidlet afdestilleret, hvorved der blev opnået et klæbrigt materiale.Then the chloroform solution was washed twice with water, dried over anhydrous sodium sulfate and concentrated. The residue formed was mixed with 20 ml of ethyl acetate to give 3.3 g of crystals. The crystals were dissolved in methanol and the solvent was distilled off to give a sticky material.

Ved omkrystallisation af materialet fra acetone blev der opnået 2 g 2,6-dimethy1-4-(3'-nitrophenyl)-l,4-dihydropyridin-3,5-dicar-boxylsyre-3^-(N-benzyl-N-methylamino )ethylester-5-methylester-hydrochlorid, smp. 180-181°C.Recrystallization of the material from acetone afforded 2 g of 2,6-dimethyl-4- (3'-nitrophenyl) -1,4-dihydropyridine-3,5-dicarboxylic acid -3- (N-benzyl-N- methylamino) ethyl ester-5-methyl ester hydrochloride, m.p. 180-181 ° C.

Produktets infrarøde absorptionsspektrum stemte overens med spektret for det produkt, der blev fremstillet i eksempel 27.The infrared absorption spectrum of the product was consistent with the spectrum of the product prepared in Example 27.

EKSEMPEL 29EXAMPLE 29

En blanding af 2,49 g 2-(3’-nitrobenzyliden)acetoeddikesyre-methyl-ester, 2,49 g acetoeddikesyre-P-(N-benzyl-N-methylamino)ethylester, 1,18 ml ammoniakvand og 10 ml ethanol blev opvarmet under tilbagesvaling i 6 timer under omrøring. Derpå blev reaktionsblandingen koncentreret, den dannede remanens blev underkastet silicagel-søjle-kromatografi, og de ønskede portioner blev elueret med en chloro-form/acetone-blanding i volumenforholdet 10:1. De udvundne portioner blev opløst i chloroform og vasket med 2 N saltsyre til indstilling af det vandige lags pH-værdi til 1-2.A mixture of 2.49 g of 2- (3'-nitrobenzylidene) acetoacetic acid methyl ester, 2.49 g of acetoacetic acid P- (N-benzyl-N-methylamino) ethyl ester, 1.18 ml of ammonia water and 10 ml of ethanol was obtained. heated at reflux for 6 hours with stirring. The reaction mixture was then concentrated, the residue formed was subjected to silica gel column chromatography and the desired portions were eluted with a 10: 1 volume ratio chloroform / acetone mixture. The recovered portions were dissolved in chloroform and washed with 2N hydrochloric acid to adjust the pH of the aqueous layer to 1-2.

Derpå blev opløsningen vasket to gange med vand, og det dannede chloroformlag blev skilt fra, tørret over vandfri natriumsulfat og koncentreret. Når der sattes ethylacetat til den dannede remanens dannedes 1,1 g krystaller. Krystallerne blev udvundet og opløst i methanol. Ved afdestillering af opløsningsmidlet blev der opnået 35 U2869 et klæbrigt materiale. Ved omkrystallisation af materialet fra acetone blev der opnået 0,7 g 2,6-dimethyl-4-(3'-nitrophenyl) 1,4-dihydorpyridin-3,5-dicarboxylsyre-3-p-(N-benzyl-N-methylamino) ethylester-5-methylester-hydrochlorid, smp. 180-181°C.Then, the solution was washed twice with water and the resulting chloroform layer was separated, dried over anhydrous sodium sulfate and concentrated. When ethyl acetate was added to the residue formed, 1.1 g of crystals formed. The crystals were recovered and dissolved in methanol. By distilling off the solvent, a sticky material was obtained. Recrystallization of the material from acetone afforded 0.7 g of 2,6-dimethyl-4- (3'-nitrophenyl) 1,4-dihydorpyridine-3,5-dicarboxylic acid 3-p- (N-benzyl-N- methylamino) ethyl ester-5-methyl ester hydrochloride, m.p. 180-181 ° C.

Produktets infrarøde absorptionsspektrum stemte overens med spektret for den forbindelse, der blev fremstillet i eksempel 27.The infrared absorption spectrum of the product was consistent with the spectrum of the compound prepared in Example 27.

EKSEMPEL 50 I 7 ml pyridin opløstes 675 mg methylamin-hydrochlorid, 2,49 g acetoeddikesyre-p-(N-benzyl-N-methylamino)ethylester, 1,17 g aceto-eddikesyre-methylester og 1,51 g m-nitrobenzaldehyd, og blandingen blev opvarmet til 90° C i 3 timer. Reaktionsblandingen blev afkølet, der tilsattes 30 ml chloroform, og opløsningen blev vasket successivt med 10 ml vand, 10 ml 2% eddikesyre, 10 ml 3% natriumhydroxidopløsning og 10 ml vand. Chloroformlaget blev tørret over vandfri magnesiumsulfat og koncentreret.EXAMPLE 50 In 7 ml of pyridine were dissolved 675 mg of methylamine hydrochloride, 2.49 g of acetoacetic acid β- (N-benzyl-N-methylamino) ethyl ester, 1.17 g of acetoacetic acid methyl ester and 1.51 g of m-nitrobenzaldehyde. and the mixture was heated to 90 ° C for 3 hours. The reaction mixture was cooled, 30 ml of chloroform was added and the solution was washed successively with 10 ml of water, 10 ml of 2% acetic acid, 10 ml of 3% sodium hydroxide solution and 10 ml of water. The chloroform layer was dried over anhydrous magnesium sulfate and concentrated.

Remanensen blev opløst i en lille mængde af en blanding af benzen og acetone i volumenforholdet 8:1 og underkastet silicagel-søjle-kromatografi (diameter 4 cm, højde 25 cm). Eluatet blev undersøgt ved tyndtlagskromatografi, og eluaterne indeholdende det ønskede produkt blev opsamlet, og de kombinerede eluater blev koncentreret til et olieagtigt materiale.The residue was dissolved in a small amount of a 8: 1 volume ratio of benzene and acetone and subjected to silica gel column chromatography (diameter 4 cm, height 25 cm). The eluate was examined by thin layer chromatography and the eluates containing the desired product were collected and the combined eluates were concentrated to an oily material.

Magnetisk kerneresonansspektrum: S(ppm): 2,20 (3H, -Ν<£5θ ) 2,48 (6H, XX ) .. h3c ^ ch3 /VW* AVW*» 2,70 (2H, -CH2-CH2-N< ) 3,20 (3H, j[NH ) 3,51 (2H, -N<CH2^0 ) 3,67 (3H, -COc£cH3 ) /Wvv 4,24 (2H, -CH2-CH2-N< ) 5,27 (IH, ) i ^ ^VN02 7 - 8,2 (9H, (5H) + (4H) } 36 142869Nuclear Magnetic Resonance Spectrum: S (ppm): 2.20 (3H, -Ν <£ 5θ) 2.48 (6H, XX) .. h3c ^ ch3 / VW * AVW * »2.70 (2H, -CH2-CH2- N <) 3.20 (3H, j [NH) 3.51 (2H, -N <CH2 O) 3.67 (3H, -COc + cH3) / Wvv 4.24 (2H, -CH2-CH2- N <) 5.27 (1H,) + VNO2 7 - 8.2 (9H, (5H) + (4H)} 36 142869

Det olieagtige materiale blev opløst i en lille mængde acetone og gjort surt med ethanolisk hydrogenchlorid, hvorved der blev opnået 1,1 g 1,2,6-trimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridin -3,5-dicarboxylsyre-3-β-(N-benzyl-N-methylamino)ethylester-5-methyl-ester-hydrochlorid.The oily material was dissolved in a small amount of acetone and acidified with ethanolic hydrogen chloride to give 1.1 g of 1,2,6-trimethyl-4- (3'-nitrophenyl) -1,4-dihydropyridine-3, 5-dicarboxylic acid 3-β- (N-benzyl-N-methylamino) ethyl ester 5-methyl ester hydrochloride.

Elementanalyse for C27H32N3°6C1: C(%) H(%) N(tf) Cl (%) beregnet: 61,19 6,08 7,93 6,69 fundet: 61,03 6,12 7,72 6,81Elemental Analysis for C27H32N3 ° 6C1: C (%) H (%) N (tf) Cl (%) Calcd: 61.19 6.08 7.93 6.69 Found: 61.03 6.12 7.72 6.81

Infrarødt absorptionsspektrum: ΚΒϊτ —1 max Cm : 2950 1686 (s)' 1521 (s^ 1342 (s)/ 1205 (s), 1150 (s), 1100 (m), 990 (w), 733 (w), 690 (w) EKSEMPEL 31 I 7 ml pyridin opløstes 675 mg methylamin-hydrochlorid, 2,48 g m-nitrobenzylidenacetoeddikesyre-methylester og 2,49 g acetoeddike-syre-β-(N-benzyl-N-methylamino)ethylester, og blandingen blev opvarmet til 90° C i 2 timer. Reaktionsblandingen blev behandlet på samme måde som i eksempel 31, hvorved der blev opnået 1,2 g 1,2,6-trimethyl- 4- (3 •-nitrophenyl )-l, 4-dihydropyridin-3,5-dicarboxylsyre-3^- (N-benzyl-N-methylamino)ethylester-5-methylester-hydrochlorid. Produktets infrarøde spektrum var identisk med spektret for forbindelsen der blev fremstillet i eksempel 31.Infrared Absorption Spectrum: ΚΒϊτ –1 max Cm: 2950 1686 (s) 1521 (s ^ 1342 (s) / 1205 (s), 1150 (s), 1100 (m), 990 (w), 733 (w), 690 (w) Example 31 In 7 ml of pyridine were dissolved 675 mg of methylamine hydrochloride, 2.48 g of m-nitrobenzylideneacetoacetic acid methyl ester and 2.49 g of acetoacetic acid β- (N-benzyl-N-methylamino) ethyl ester and the mixture was heated to 90 ° C for 2 hours The reaction mixture was treated in the same manner as in Example 31 to give 1.2 g of 1,2,6-trimethyl-4- (3-nitrophenyl) 1,4-dihydropyridine -3,5-dicarboxylic acid -3- (N-benzyl-N-methylamino) ethyl ester-5-methyl ester hydrochloride The infrared spectrum of the product was identical to the spectrum of the compound prepared in Example 31.

EKSEMPEL 32 a) I 340 ml isopropylalkohol opløstes 82 g råt m-nitrobenzaldehyd, 135 S rå ac eto eddike syre-β-(N-benzyl-N-methylamino)ethylester og 63 g rå β-aminocrotonsyre-methylester, og reaktionsblandingen blev opvarmet under tilbagesvaling i 6 timer under omrøring. Efter reaktionens afslutning sattes 580 ml methylenchlorid til reaktionsblandingen. Opløsningen blev vasket med en saltsyreopløsning bestående af 92 ml koncentreret saltsyre og 320 ml vand, derpå med 240 ml vand og til sidst med en saltsyreopløsning bestående af 40 ml koncentreret saltsyre og 240 ml vand. Det organiske lag blev 37 142869 skilt fra og tørret over vandfrit natriumsulfat, hvorpå opløsningsmidlet blev afdestilleret. Der sattes 1500 ml ethylacetat til den således opnåede remanens, og opløsningen blev omrørt natten over ved stuetemperatur. Det dannede bundfald blev opsamlet og vasket med ethylacetat, hvorved der blev opnået 200 g krystaller.EXAMPLE 32 (a) In 340 ml of isopropyl alcohol, 82 g of crude m-nitrobenzaldehyde, 135 S crude ac etoacetic acid β-(N-benzyl-N-methylamino) ethyl ester and 63 g crude β-aminocrotonic acid methyl ester were dissolved and the reaction mixture heated. under reflux for 6 hours with stirring. At the end of the reaction, 580 ml of methylene chloride was added to the reaction mixture. The solution was washed with a hydrochloric acid solution consisting of 92 ml of concentrated hydrochloric acid and 320 ml of water, then with 240 ml of water and finally with a hydrochloric acid solution consisting of 40 ml of concentrated hydrochloric acid and 240 ml of water. The organic layer was separated and dried over anhydrous sodium sulfate, and the solvent was distilled off. 1500 ml of ethyl acetate was added to the residue thus obtained and the solution was stirred overnight at room temperature. The precipitate formed was collected and washed with ethyl acetate to give 200 g of crystals.

b)-l. 130 g af de ovenfor opnåede krystaller blev suspenderet i 900 ml methylenchlorid, og der sattes 450 ml vand til suspensionen efterfulgt af omrøring i 30 minutter. Det organiske lag blev skilt fra og vasket to gange, hver gang med 360 ml vand og derefter en gang med en saltsyreopløsning bestående af 22 ml koncentreret saltsyre og 360 ml vand, hvorpå opløsningen blev tørret over vandfrit natriumsulfat. Opløsningsmidlet blev afdestilléret, og den således opnåede karamel-lignende remanens blev opløst i 800 ml acetone. Opløsningen blev omrørt natten over under isafkøling, hvorved der blev opnået 93 g β-type-krystaller af 2,6-dimethyl-4-(3'-nitrophenyl)- 1.4- dihydropyridin-3,5-dicarboxylsyre-5-methylester-3-P-(N-benzyl-N-methylamino)ethylester-hydrochlorid, som havde et smeltepunkt på 168-170°C.b) -l. 130 g of the crystals obtained above were suspended in 900 ml of methylene chloride and 450 ml of water was added to the suspension followed by stirring for 30 minutes. The organic layer was separated and washed twice, each with 360 ml of water and then once with a hydrochloric acid solution consisting of 22 ml of concentrated hydrochloric acid and 360 ml of water, and the solution was dried over anhydrous sodium sulfate. The solvent was distilled off and the caramel-like residue thus obtained was dissolved in 800 ml of acetone. The solution was stirred overnight under ice-cooling to obtain 93 g of β-type crystals of 2,6-dimethyl-4- (3'-nitrophenyl) -1,4-dihydropyridine-3,5-dicarboxylic acid 5-methyl ester-3 -P- (N-benzyl-N-methylamino) ethyl ester hydrochloride, which had a melting point of 168-170 ° C.

b)-2. 100 g af de under (a) opnåede krystaller blev suspenderet i 700 ml methylenchlorid, og der sattes 340 ml vand til suspensionen efterfulgt af omrøring i 30 minutter. Det organiske lag blev skilt fra og vasket to gange, hver gang med 270 ml vand og en gang med en saltsyreopløsning bestående af 16 ml koncentreret saltsyre og 270 ml vand, hvorefter opløsningen blev tørret over vandfrit natriumsulfat. Opløsningsmidlet blev afdestilleret, og den således karamel-lignende remanens blev opløst i 500 ml acetone. Opløsningen fik lov at stå natten over ved stuetemperatur. Det dannede bundfald blev opsamlet og vasket med acetone, hvorved der blev opnået 70 g a-type-krystaller af 2,6-dimethyl-4-(3’-nitrophenyl)- 1.4- dihydropyridin-3,5-dicarboxylsyre-5-methylester-3-p-(N-benzyl-N-methylamino)ethylester-hydrochlorid, som havde et smeltepunkt på 179-181®C.b) -2. 100 g of the crystals obtained under (a) were suspended in 700 ml of methylene chloride and 340 ml of water was added to the suspension followed by stirring for 30 minutes. The organic layer was separated and washed twice, each with 270 ml of water and once with a hydrochloric acid solution consisting of 16 ml of concentrated hydrochloric acid and 270 ml of water, after which the solution was dried over anhydrous sodium sulfate. The solvent was distilled off and the thus caramel-like residue was dissolved in 500 ml of acetone. The solution was allowed to stand overnight at room temperature. The precipitate formed was collected and washed with acetone to give 70 g of α-type crystals of 2,6-dimethyl-4- (3'-nitrophenyl) 1,4-dihydropyridine-3,5-dicarboxylic acid 5-methyl ester -3-p- (N-benzyl-N-methylamino) ethyl ester hydrochloride having a melting point of 179-181 ° C.

Claims (1)

38 142869 Pat entkrav: Analogifremgangsmåde til fremstilling af 2,6-dialkyl-4-phenyl-l,4-dihydropyridin-3-carboxylsyre-aminoalkylester-forbindelser med den almene formel iv R5-0O. Xy^00-^·\ 4 (I) i: hvori A betyder alkylen med 1-4 carbonatomer, R betyder hydrogen 1 2. eller alkyl med 1-4 carbonatomer, R og R , som kan være ens eller forskellige, betyder alkyl med 1-4 carbonatomer, R betyder en phe-nylgruppe eller en benzylgruppe som kan være substitueret med en alkyl- eller alkoxygruppe med 1-4 carbonatomer eller et halogenatom, 4 , 5 R betyder hydrogen eller alkyl med 1-4 carbonatomer, R betyder alkyl med 1-4 carbonatomer, alkoxy med 1-6 carbonatomer, som kan være substitueret med en alkoxygruppe med 1-4 carbonatomer, eller -0-A-NR^R4 , hvor A, R^ og R4 har den ovennævnte betydning, og R^ betyder nitro eller trifluormethyl eller farmaceutisk acceptable syreadditionssalte deraf, kendetegnet ved, (a) at et benzaldehyd-derivat med formlen Al * I--R6 (II) CHO C hvori R har den ovenfor angivne betydning, omsættes med en lavere-alkanoyleddikesyre-aminoalkylester med formlen V R2-C0-CH2C00-A-N (III) R4 39 142869 2 3 4 hvori R , R , R og A har den ovenfor angivne betydning, og en enamin med formlen R1-C=CH-C0R1 (IV) NH-R 1 5 hvori R, R og R har den ovenfor angivne betydning, hvilken enamin er fremstillet ved omsætning af en forbindelse med formlen r1-co-ch2-cor1 (V) 15 hvori R og R har den ovenfor angivne betydning, og en forbindelse med formlen r-nh2 (XVI) hvori R har den ovenfor angivne betydning, eller (b) at et benzaldehyd-derivat med formlen f^-R2 (II) CHO r hvori R° har den ovenfor angivne betydning, omsættes med en β-amino-acrylsyre-aminoalkylester med formlen . R3 4 5-C=CH-C00-A-N< (VI) NHR ^R^ 15 2 hvori R og R har den ovenfor angivne betydning, hvilken β-amino-acrylsyre-aminoalkylester er fremstillet ved omsætning af en forbindelse med formlen 3 3 4 4 hvori R, R , R , R og A har den ovenfor angivne betydning, og en β-diketon med formlen 5 R^CO-CHgCOR1 (V) 142869 40 R2-C0CH2C00-A-N (III) R4 074 hvori R , R, R og A har den ovenfor angivne betydning, og en forbindelse med formlen R-NH2 (XVI) hvori R har den ovenfor angivne betydning, eller (c) at en lavere-alkanoylkanelsyre-alkylester med formlen „6 ff '^V- CH=C-C00-A-N / ^711 ^ \=J COR2 ^ r4 hvori R2, R^, R^, R^ og A har den ovenfor angivne betydning, omsættes med et enaminderivat med formlen R1-C=CH-C0R5 (IV) NHR hvori R, R^ og R-* har den ovenfor angivne betydning, eller (d) at en lavere-alkylstyrylketon med formlen 6CH-C-C0R5 COR1 hvori R^, R^ og R^ har den ovenfor angivne betydning, omsættes med en enaminforbindelse med formlen s# r2-c=ch-coo-a-n^ (vi) j \.«4 NHR XR^ 41 142869 hvori R, R2, R^, R^ og A har den ovenfor angivne betydning, eller (e) at en lavere-alkanoylkanelsyrealkylester med formlen Å V V—CH=C-C00-A-NC ,, (VII) \=/ éoR2 VR hvori R2, R^, r\ R^ og A har den ovenfor angivne betydning, omsættes med en β-diketonforbindeIse med formlen r1-co-ch2-cor5 (V) hvori R1 og R^ har den ovenfor angivne betydning, og en amin med formlen r-nh2 (XIV) hvori R har den ovenfor angivne betydning, eller (f) at en lavere-alkylstyrylketon med formlen R6 // \y CH=C-COR5 (VIII) \=zf COR1 hvori R1, R^ og R^ har den ovenfor angivne betydning omsættes med en lavere-alkanoyleddike syre- amino-alkylester med formlen r2-co-ch2-coo-a-n^4 (III) hvori R2, R3, R^ og A har den ovenfor angivne betydning, og en amin med formlen r-nh2 (XVI) 142869 42 hvori R har den. ovenfor angivne betydning, eller (g) at et benzaldehyd-derivat med formlen Q-‘ CHO £ hvori R har den ovenfor angivne betydning, omsættes med en al-kanoyleddikesyre-aminoalkylester med formlen /r3 R2-C0-CHo-C00-A-N^ (III) 2 'v o A hvori R , R og R har den ovenfor angivne betydning, en β-diketon med formlen r1-co-ch2-co-r5 (V) hvori R1 og R^ har den ovenfor angivne betydning, og en amin med formlen r-nh2 (XVI) hvori R har den ovenfor angivne betydning, eller (h) at et benzaldehyd-derivat med formlen jT^j-R6 (II) CHO g hvori R har den ovenfor angivne betydning, omsættes med en enamin med formlenPatent claim: Analogous process for preparing 2,6-dialkyl-4-phenyl-1,4-dihydropyridine-3-carboxylic acid aminoalkyl ester compounds of general formula iv R5-0O. Xy ^ 00-- 4 4 (I) i: wherein A means alkylene of 1-4 carbon atoms, R means hydrogen of 2 or alkyl of 1-4 carbon atoms, R and R which may be the same or different, means alkyl with 1-4 carbon atoms, R means a phenyl group or a benzyl group which may be substituted by an alkyl or alkoxy group having 1-4 carbon atoms or a halogen atom, 4.5 represents R hydrogen or alkyl of 1-4 carbon atoms, R means alkyl of 1-4 carbon atoms, alkoxy of 1-6 carbon atoms which may be substituted by an alkoxy group of 1-4 carbon atoms, or -O-A-NR 2 R 4, wherein A, R 1 and R 4 have the above meaning, and R 1 is nitro or trifluoromethyl or pharmaceutically acceptable acid addition salts thereof, characterized in that (a) a benzaldehyde derivative of the formula Al * I - R 6 (II) CHO C wherein R has the above meaning is reacted with a lower alkanoyl acetic acid -aminoalkyl ester of the formula V R2-CO-CH 2 CO-AN (III) R4 39 14 2 69 4 wherein R, R, R and A have the o and Enamine of the formula R 1 -C = CH-COR 1 (IV) NH-R 15 wherein R, R and R are as defined above, which enamine is prepared by reacting a compound of formula R -ch2-cor1 (V) wherein R and R are as defined above and a compound of formula r-nh2 (XVI) wherein R is as defined above, or (b) that a benzaldehyde derivative of formula f -R2 (II) CHOr wherein R ° has the meaning given above is reacted with a β-amino-acrylic acid aminoalkyl ester of the formula. R3 4 5-C = CH-C00-AN <(VI) NHR ^ R ^ 15 wherein R and R are as defined above, which β-amino-acrylic acid aminoalkyl ester is prepared by reaction of a compound of formula 3 3 Wherein R, R, R, R and A are as defined above and a β-diketone of the formula 5 R 2 CO-CH 2 COOR 1 (V) 14-COCH 2 CO-AN (III) R 4 074 wherein R, R , R and A are as defined above and a compound of formula R-NH 2 (XVI) wherein R is as defined above, or (c) a lower alkanoylcinnamic acid alkyl ester of formula "6 ff" = C-C00-AN / ^ 711 ^ \ = J COR2 ^ r4 wherein R2, R ^, R ^, R ^ and A are as defined above, reacted with an enamine derivative of the formula R1-C = CH-COR5 (IV ) NHR wherein R, R 1 and R 4 have the meaning given above, or (d) reacting a lower-alkyl styryl ketone of the formula 6CH-C-COR5 COR1 wherein R 1, R 2 and R 2 have the meaning given above with an enamine compound of the formula s # r2-c = ch-coo-an ^ (vi) j \ Wherein R, R2, R4, R4 and A are as defined above, or (e) that a lower alkanoyl cinnamic acid alkyl ester of the formula ZVV-CH = C-C00-A-NC; , (VII) \ = / éoR2 VR wherein R2, R ^, r \ R ^ and A are as defined above are reacted with a β-diketone compound of the formula r1-co-ch2-cor5 (V) wherein R1 and R has the meaning given above and an amine of formula r-nh2 (XIV) wherein R has the meaning given above, or (f) that a lower alkyl styryl ketone of formula R6 // \ y CH = C-COR5 (VIII) \ = zf COR1 wherein R 1, R 2 and R 2 have the meaning given above are reacted with a lower-alkanoyl acetic acid amino-alkyl ester of the formula r 2 -co-ch 2 -cooan 4 (III) wherein R 2, R 3, R 2 and A is as defined above and an amine of formula r-nh2 (XVI) wherein R is. or (g) that a benzaldehyde derivative of formula Q - CHO wherein R has the meaning given above is reacted with an alkanoylacetic acid aminoalkyl ester of formula / R3 R2-CO-CHO-C00-AN (III) 2 'vo A wherein R, R and R have the meaning given above, a β-diketone of the formula r1-co-ch2-co-r5 (V) wherein R 1 and R 2 have the meaning given above, and a amine of formula r-nh 2 (XVI) wherein R is as defined above, or (h) a benzaldehyde derivative of formula jT-j-R6 (II) CHO g wherein R is as defined above is reacted with an enamine with the formula
DK87774AA 1973-02-20 1974-02-19 Analogous process for preparing 2,6-dialkyl-4-phenyl-1,4-dihydropyridine-3-carboxylic acid aminoalkyl ester compounds. DK142869B (en)

Applications Claiming Priority (16)

Application Number Priority Date Filing Date Title
JP2042373 1973-02-20
JP48020423A JPS5930704B2 (en) 1973-02-20 1973-02-20 Method for producing new 1,4-dihydropyridine derivatives
JP2556673 1973-03-03
JP2556673A JPS49109384A (en) 1973-03-03 1973-03-03
JP4482173 1973-04-20
JP4482173A JPS5714348B2 (en) 1973-04-20 1973-04-20
JP5230773A JPS49135976A (en) 1973-05-11 1973-05-11
JP5230773 1973-05-11
JP5493973 1973-05-17
JP5493973A JPS504082A (en) 1973-05-17 1973-05-17
JP8327673 1973-07-24
JP8327673A JPS5720950B2 (en) 1973-07-24 1973-07-24
JP13407073 1973-11-29
JP13407073A JPS5084577A (en) 1973-11-29 1973-11-29
JP13406973A JPS5545075B2 (en) 1973-11-29 1973-11-29
JP13406973 1973-11-29

Publications (2)

Publication Number Publication Date
DK142869B true DK142869B (en) 1981-02-16
DK142869C DK142869C (en) 1981-09-28

Family

ID=27571887

Family Applications (1)

Application Number Title Priority Date Filing Date
DK87774AA DK142869B (en) 1973-02-20 1974-02-19 Analogous process for preparing 2,6-dialkyl-4-phenyl-1,4-dihydropyridine-3-carboxylic acid aminoalkyl ester compounds.

Country Status (8)

Country Link
CA (1) CA1023746A (en)
CH (1) CH605755A5 (en)
DE (1) DE2407115C3 (en)
DK (1) DK142869B (en)
FI (1) FI58772C (en)
GB (1) GB1455502A (en)
NL (2) NL176559C (en)
NO (1) NO143846C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK152285B (en) * 1975-07-02 1988-02-15 Fujisawa Pharmaceutical Co METHOD OF ANALOGY FOR THE PREPARATION OF 1,4-DIHYDROPYRIDINE DERIVATIVES

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55301A (en) * 1978-02-14 1980-01-05 Yamanouchi Pharmaceut Co Ltd 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its preparation
DE2815578C2 (en) * 1978-04-11 1986-01-16 Bayer Ag, 5090 Leverkusen New pharmaceutical use of nimodipine
IT1097538B (en) * 1978-07-17 1985-08-31 Medea Res Srl PROCESS FOR THE PREPARATION OF 2,6-DIMETHYL-4-3 (3-NITROFENIL) -3-METOXYCARBONYL-1,4-DIDROPYRIDIN-5-CARBOXYLATE OF 2 (N-BENZYL-N-METHYLAMINE)
DE2949464A1 (en) * 1978-12-18 1980-06-26 Sandoz Ag BENZOXADIAZOLES AND BENZOTHIADIAZOLES, THEIR PRODUCTION AND USE
JPS5762257A (en) * 1980-10-03 1982-04-15 Yoshitomi Pharmaceut Ind Ltd 1,4-dihydropyridine-3,5-dicarboxylic acid ester or its salt
JPS57200386A (en) * 1981-06-04 1982-12-08 Yoshitomi Pharmaceut Ind Ltd Novel 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its salts
WO1983003249A1 (en) * 1982-03-17 1983-09-29 Yoshitomi Pharmaceutical 1,4-dihydropyridine-3,5-dicarboxylate derivatives
EP0094159B1 (en) * 1982-05-10 1990-03-14 Takeda Chemical Industries, Ltd. Dihydropyridine derivatives, their production and use
ATE52030T1 (en) * 1984-01-13 1990-05-15 Yamanouchi Pharma Co Ltd MEDICATIONS FOR THE TREATMENT AND PREVENTION OF LIVER INJURIES.
AT388375B (en) * 1984-04-11 1989-06-12 Bristol Myers Co METHOD FOR PRODUCING NEW DIHYDROPYRIDINE CARBONIC ACID AMIDES AND ESTERS
JPS6289662A (en) * 1985-06-14 1987-04-24 Sankyo Co Ltd 1,4-dihydropyridine derivative
DE3531498A1 (en) * 1985-09-04 1987-03-05 Bayer Ag DIHYDROPYRIDIN-2-HYDROXYAMINE, METHOD FOR THE PRODUCTION AND THEIR USE IN MEDICINAL PRODUCTS
DE3621104A1 (en) * 1986-06-24 1988-01-07 Heumann Pharma Gmbh & Co 1,4-DIHYDROPYRIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
US4772596A (en) * 1986-10-09 1988-09-20 Sankyo Company Limited Dihydropyridine derivatives, their preparation and their use
YU45837B (en) * 1988-01-18 1992-07-20 LEK TOVARNA FARMACEVTSKIH IN KEMIČKIH IZDELKOV d.d. PROCEDURE FOR PREPARATION OF THE NEW NICARDIPINE INCLUSION COMPLEX OZ. ITS HYDROCHLORIDE WITH BETA-CYCLODEXTRIN
NL9001752A (en) * 1990-08-02 1992-03-02 Cedona Pharm Bv NEW 1,4-DIHYDROPYRIDINE DERIVATIVES.
EP0985667A4 (en) * 1997-04-25 2000-03-22 Ajinomoto Kk Novel dihydropyridine derivative
ES2332168B1 (en) * 2008-04-30 2010-10-27 Consejo Superior De Investigaciones Cientificas (Csic) (75%) PSEUDOPOLIMORFICA FORM OF NICARDIPINE HYDROCLORIDE, PROCEDURE FOR PREPARATION AND FORMULATION CONTAINING IT.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK152285B (en) * 1975-07-02 1988-02-15 Fujisawa Pharmaceutical Co METHOD OF ANALOGY FOR THE PREPARATION OF 1,4-DIHYDROPYRIDINE DERIVATIVES

Also Published As

Publication number Publication date
NO143846B (en) 1981-01-12
DK142869C (en) 1981-09-28
NL930023I2 (en) 1997-08-01
FI58772B (en) 1980-12-31
GB1455502A (en) 1976-11-10
DE2407115A1 (en) 1974-10-10
DE2407115C3 (en) 1980-05-08
NL176559B (en) 1984-12-03
DE2407115B2 (en) 1979-08-09
FI58772C (en) 1981-04-10
NL176559C (en) 1985-05-01
NL930023I1 (en) 1993-05-17
CH605755A5 (en) 1978-10-13
NL7402277A (en) 1974-08-22
NO143846C (en) 1981-04-29
CA1023746A (en) 1978-01-03
AU6565574A (en) 1975-08-21
NO740543L (en) 1974-08-21

Similar Documents

Publication Publication Date Title
DK142869B (en) Analogous process for preparing 2,6-dialkyl-4-phenyl-1,4-dihydropyridine-3-carboxylic acid aminoalkyl ester compounds.
US3985758A (en) 1,4-Dihydropyridine derivatives
US4727066A (en) Esters of 1,4-dihydropyridines and medicaments containing the same
IE57715B1 (en) Asymmetrical diesters of 1,4-dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylic acid
CS228506B2 (en) Method for the production of optical active ester of 1,4-dihydropyridincarboxyl acid
KR920005742B1 (en) Process for the preparation of pharmaceutically useful dihydropyridinyl dicanboxylate amide and esters
PL185099B1 (en) Shortly acting dihydropyridines
US3691177A (en) Cyanophenyl-1,4-dihydropyridine derivatives
SE446265B (en) 2-methyl-1,4-dihydropyridine
DK149855B (en) METHOD OF ANALOGY FOR THE PREPARATION OF 1,4-DIHYDROPYRIDINE DERIVATIVES
US4021434A (en) Sodium β-[2,6-dimethyl-3,5-bis(ethoxycarbonyl)-4-(3-nitrophenyl)-1,4-dihydropyridine-1-yl]ethyl sulfate
Leonardi et al. Asymmetric N-(3, 3-diphenylpropyl) aminoalkyl esters of 4-aryl-2, 6-dimethyl-1, 4-dihydropyridine-3, 5-dicarboxylic acids with antihypertensive activity
US4895846A (en) Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters incorporating arylpiperazinylalkyl moieties
Taylor et al. 2-(2-Aryl-2-oxoethylidene)-1, 2, 3, 4-tetrahydropyridines. Novel isomers of 1, 4-dihydropyridine calcium channel blockers
EP0106276B1 (en) 1,4-dihydropyridine derivatives
IE43984B1 (en) A 1,4-dihydropyridine-3 5-dicarboxylic acid di-ester derivative, several processes for its preparation,and its use as a coronary therapeutic agent
US4442106A (en) Quinoline derivatives, pharmaceutical compositions containing such compounds, and methods of treating cardiovascular conditions with them
SU718011A3 (en) Method of producing phenylthieno-(2,3-c) piperidine derivatives or salts thereof
JP2640245B2 (en) 1,4-dihydropyridine derivative
US4742068A (en) Dihydropyridine compounds having 1,4,4-trisubstitution useful as antihypertensive agents
JPS6251672A (en) Novel 2-(4-phenyl-1-piperazinyl alkyl)-aminopyrimidine derivative and acid addition salt thereof
US4843085A (en) Pyridine derivatives, process for production thereof and pharmaceutical compositions useful as anti-arhytmics
NL8004002A (en) QUINOLINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH A COMPOUND AND METHOD FOR PREPARING THESE COMPOUNDS.
EP0164213B1 (en) Esters of 1,4-dihydro-2,6-dimethyl-3-(alkoxycarbonyl or alkoxyalkoxycarbonyl)-4-(substituted phenyl)-pyridine-5-carboxylic acid
EP0285267A2 (en) Pyridine derivatives for treatment and prevention of liver damage, and their preparation

Legal Events

Date Code Title Description
PUP Patent expired